Comfort Pack reduces anxiety, improves care: emergency meds decrease visits to the ED. Hospital Home Health. 2008;25(8):92–93.

‘Just in case’ boxes improve access to palliative care drugs. Nursing Older People. 2011;23(4):4.

Low eGFR and high albuminuria predict end stage kidney disease and death at all ages. BMJ. 2012;345(7882) [PubMed: 23135200]

Abarshi E, Echteld M, Donker G, Van den Block L, Onwuteaka-Philipsen B, Deliens L. Discussing end-of-life issues in the last months of life: a nationwide study among general practitioners. Journal of Palliative Medicine. 2011;14(3) [PubMed: 21254811]

Abarshi EA, Echteld MA, Van den Block L, Donker GA, Deliens L, Onwuteaka-Philipsen BD. Recognising patients who will die in the near future: a nationwide study via the Dutch Sentinel Network of GPs. British Journal of General Practice. 2011;61(587):e371–e378. [PMC free article: PMC3103701] [PubMed: 21801517]

Abbott KH, Sago JG, Breen CM, Abernethy AP, Tulsky JA. Families looking back: one year after discussion of withdrawal or withholding of life-sustaining support. Critical Care Medicine. 2001;29(1):197–201. [PubMed: 11176185]

Abdul-Razzak A, You J, Sherifali D, Simon J, Brazil K. ‘Conditional candour’ and ‘knowing me’: an interpretive description study on patient preferences for physician behaviours during end-of-life communication. BMJ Open. 2014;4(10) [PMC free article: PMC4194750] [PubMed: 25296653]

Abernethy AP. Palliative oxygen and room air did not differ for relief of breathlessness in patients with refractory dyspnea. Annals of Internal Medicine. 2011;154(4):JC2. [PubMed: 21320929]

Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ (Clinical Research Ed ). 2003;327(7414):523–528. [PMC free article: PMC192892] [PubMed: 12958109]

Abernethy AP, McDonald CF, Frith PA, Clark K, Herndon JE, Marcello J, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. The Lancet. 2010;376(9743):784–793. [PMC free article: PMC2962424] [PubMed: 20816546]

Adamolekun K. Openness of health professionals about death and terminal illness in a Nigerian teaching hospital. Omega: Journal of Death and Dying. 1998;36(1) [PubMed: 11655258]

Adams JA, Anderson RA, Docherty SL, Tulsky JA, Steinhauser KE, Bailey DEJ. Nursing strategies to support family members of ICU patients at high risk of dying. Heart and Lung. 2014;43(5):406–415. [PMC free article: PMC4150813] [PubMed: 24655938]

Addicott R. Delivering better end-of-life care in England: barriers to access for patients with a non-cancer diagnosis. Health Economics, Policy, and Law. 2012;7(4):441–454. [PubMed: 23079302]

Adelman HM, Wallach PM, Boero JF, Crakovich D, Halbritter KA, Johnston S, et al. The discussion of end-of-life medical care by primary care patients and physicians: A multicenter study using structured qualitative interviews. Journal of General Internal Medicine. 1994;9(2) [PubMed: 8164082]

Ahamed A, Ahmedzai SH. Breathlessness in advanced disease. Medicine. 2011;39(11):651–655.

Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. Journal of Pain and Symptom Management. 1997;13(5):254–261. [PubMed: 9185430]

Ahmedzai SH, Laude E, Robertson A, Troy G, Vora V. A double-blind, randomised, controlled Phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion. British Journal of Cancer. 2004;90(2):366–371. [PMC free article: PMC2409543] [PubMed: 14735178]

Al DE, Pang J, Kiuok S, Chow E. Predictive models of survival in patients with advanced cancer. Asia-Pacific Journal of Oncology and Hematology. 2010;2(1):121–130.

Al-Zahrani AS, El-Kashif AT, Mohammad AA, Elsamany S, Alsirafy SA. Prediction of in-hospital mortality of patients with advanced cancer using the Chuang Prognostic Score. American Journal of Hospice and Palliative Care. 2013;30(7):707–711. [PubMed: 23271407]

Allard P, Lamontagne C, Bernard P, Tremblay C. How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial. Journal of Pain and Symptom Management. 1999;17(4):256–265. [PubMed: 10203878]

Almack K, Cox K, Moghaddam N, Pollock K, Seymour J. After you: conversations between patients and healthcare professionals in planning for end of life care. BMC Palliative Care. 2012;11:15. [PMC free article: PMC3517317] [PubMed: 22985010]

Amass C, Allen M. How a “just in case” approach can improve out-of-hours palliative care. Pharmaceutical Journal. 2005;275(7356):22–23.

Andersen JB. Optimizing ventilatory settings using pulse oximetry in the transition between life and death. Scandinavian Journal of Clinical and Laboratory Investigation. 1988;48(SUPPL. 189):59–61.

Anderson AK, Breen M. Evaluating a palliative care services: Our experience of the role of “a professional users” survey” as an evaluating tool. Archives of Disease in Childhood. 2010;95

Anderson SL, Shreve ST. Continuous subcutaneous infusion of opiates at end-of-life. Annals of Pharmacotherapy. 2004;38(6):1015–1023. [PubMed: 15122000]

Anderson WG, Kools S, Lyndon A. Dancing around death: hospitalist-patient communication about serious illness. Qualitative Health Research. 2013;23(1):1–15. [PMC free article: PMC3502664] [PubMed: 23034778]

Anquinet L, Rietjens JA, Mathers N, Seymour J, van der Heide A, Deliens L. Descriptions by general practitioners and nurses of their collaboration in continuous sedation until death at home: in-depth qualitative interviews in three European countries. Journal of Pain and Symptom Management. 2015;49(1):98–109. [PubMed: 24906190]

Anselm AH, Palda V, Guest CB, McLean RF, Vachon MLS, Kelner M, et al. Barriers to communication regarding end-of-life care: perspectives of care providers. Journal of Critical Care. 2005;20(3):214–223. [PubMed: 16253789]

Apatira L, Boyd EA, Malvar G, Evans LR, Luce JM, Lo B, et al. Hope, truth, and preparing for death: perspectives of surrogate decision makers. Annals of Internal Medicine. 2008;149(12) [PMC free article: PMC2622736] [PubMed: 19075205]

Asch A. Recognizing death while affirming life: can end of life reform uphold a disabled person's interest in continued life? Hastings Center Report. 2005.:S31–S36. Spec No. [PubMed: 16468253]

Aslakson RA, Wyskiel R, Thornton I, Copley C, Shaffer D, Zyra M, et al. Nurse-perceived barriers to effective communication regarding prognosis and optimal end-of-life care for surgical ICU patients: a qualitative exploration. Journal of Palliative Medicine. 2012;15(8) [PMC free article: PMC3396137] [PubMed: 22676315]

Aurora RN, Chowdhuri S, Ramar K, Bista SR, Casey KR, Lamm CI, et al. The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses. Sleep. 2012;35(1):17–40. [PMC free article: PMC3242685] [PubMed: 22215916]

Azoulay E, Timsit JF, Sprung CL, Soares M, Rusinova K, Lafabrie A, et al. Prevalence and factors of intensive care unit conflicts: the conflicus study. American Journal of Respiratory and Critical Care Medicine. 2009;180(9) [PubMed: 19644049]

Bach JR, Goncalves MR, Hon A, Ishikawa Y, De Vito EL, Prado F, et al. Changing trends in the management of end-stage neuromuscular respiratory muscle failure: recommendations of an international consensus. American Journal of Physical Medicine and Rehabilitation. 2013;92(3):267–277. [PubMed: 23051760]

Bach V, Ploeg J, Black M. Nursing Roles in End-of-Life Decision Making in Critical Care Settings. Western Journal of Nursing Research. 2009;31(4):496–512. [PubMed: 19208850]

Bachner YG, Yosef-Sela N, Carmel S. Open communication with terminally ill cancer patients about illness and death: a comparison between spouses of Ashkenazi and Sephardi ethnic origins. Cancer Nursing. 2014;37(1):50–58. [PubMed: 23348664]

Back IN, Jenkins K, Blower A, Beckhelling J. A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle. Palliative Medicine. 2001;15(4):329–336. [PubMed: 12054150]

Bailey FA, Burgio KL, Woodby LL, Williams BR, Redden DT, Kovac SH, et al. Improving processes of hospital care during the last hours of life. Archives of Internal Medicine. 2005;165(15):1722–1727. [PubMed: 16087819]

Bailey FA, Williams BR, Goode PS, Woodby LL, Redden DT, Johnson TM, et al. Opioid pain medication orders and administration in the last days of life. Journal of Pain and Symptom Management. 2012;44(5):681–691. [PubMed: 22765968]

Bailey FA, Williams BR, Woodby LL, Goode PS, Redden DT, Houston TK, et al. Intervention to improve care at life's end in inpatient settings: the BEACON trial. Journal of General Internal Medicine. 2014;29(6):836–843. [PMC free article: PMC4026508] [PubMed: 24449032]

Bajwah S, Koffman J, Higginson IJ, Ross JR, Wells AU, Birring SS, et al. ‘I wish I knew more …’ the end-of-life planning and information needs for end-stage fibrotic interstitial lung disease: views of patients, carers and health professionals. BMJ Supportive and Palliative Care. 2013;3(1):1–6. [PubMed: 24644332]

Bajwah S, Ross JR, Peacock JL, Higginson IJ, Wells AU, Patel AS, et al. Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature. Thorax. 2013;68(9):867–879. [PubMed: 23204065]

Bakitas M, Ahles TA, Skalla K, Brokaw FC, Byock I, Hanscom B, et al. Proxy perspectives regarding end-of-life care for persons with cancer. Cancer. 2008;112(8):1854–1861. [PMC free article: PMC3638939] [PubMed: 18306393]

Bandieri E, Sichetti D, Romero M, Fanizza C, Belfiglio M, Buonaccorso L, et al. Impact of early access to a palliative/supportive care intervention on pain management in patients with cancer. Annals of Oncology. 2012;23(8):2016–2020. [PubMed: 22565123]

Barbera L, Paszat L, Qiu F. End-of-life care in lung cancer patients in Ontario: aggressiveness of care in the population and a description of hospital admissions. Journal of Pain and Symptom Management. 2008;35(3):267–274. [PubMed: 18248949]

Barrett BJ, Parfrey PS, Morgan J, Barre P, Fine A, Goldstein MB, et al. Prediction of early death in end-stage renal disease patients starting dialysis. American Journal of Kidney Diseases. 1997;29(2):214–222. [PubMed: 9016892]

Barry LC, Prigerson HG. Perspectives on preparedness for a death among bereaved persons. Connecticut Medicine. 2002;66(11):691–696. [PubMed: 12476512]

Bausewein C, Simon ST. Shortness of breath and cough in patients in palliative care. Deutsches Arzteblatt International. 2013;110(33-34):563–572. [PMC free article: PMC3782037] [PubMed: 24069091]

Beckstrand RL, Smith MD, Heaston S, Bond AE. Emergency nurses' perceptions of size, frequency, and magnitude of obstacles and supportive behaviors in end-of-life care. Journal of Emergency Nursing: JEN. 2008;34(4):290–300. [PubMed: 18640407]

Bekkema N, de Veer AJE, Hertogh CMPM, Francke AL. Respecting autonomy in the end-of-life care of people with intellectual disabilities: A qualitative multiple-case study. Journal of Intellectual Disability Research. 2014;58(4):386–380. [PubMed: 23510011]

Ben-Aharon I, Gafter-Gvili A, Paul M, Leibovici L, Stemmer SM. Interventions for alleviating cancer-related dyspnea: a systematic review. Journal of Clinical Oncology. 2008;26(14):2396–2404. [PubMed: 18467732]

Ben-Aharon I, Gafter-Gvili A, Leibovici L, Stemmer SM. Interventions for alleviating cancer-related dyspnea: a systematic review and meta-analysis. Acta Oncologica. 2012;51(8):996–1008. [PubMed: 22934558]

Benitez-Rosario MA, Feria M, Salinas-Martin A, Martinez-Castillo LP, Martin-Ortega JJ. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain. Cancer. 2004;101(12):2866–2873. [PubMed: 15529307]

Bern-Klug M. Calling the question of “possible dying” among nursing home residents: triggers, barriers, and facilitators. Journal of Social Work in End-of-Life and Palliative Care. 2006;2(3):61–85. [PubMed: 17387090]

Bern-Klug M, essert CE, renner CW, uenaver M, kirchak D. “Getting everyone on the same page”: nursing home physicians' perspectives on end-of-life care. Journal of Palliative Medicine. 2004;7(4):533–544. [PubMed: 15353097]

Biola H, Sloane PD, Williams CS, Daaleman TP, Williams SW, Zimmerman S. Physician communication with family caregivers of long-term care residents at the end of life. Journal of the American Geriatrics Society. 2007;55(6):846–856. [PubMed: 17537084]

Boland E, Johnson M, Boland J. Artificial hydration in the terminally ill patient. British Journal of Hospital Medicine. 2013;74(7):397–401. [PubMed: 24159642]

Boot M, Wilson C. Clinical nurse specialists perspectives on advance care planning conversations: a qualitative study. International Journal of Palliative Nursing. 2014;20(1):9–14. [PubMed: 24464168]

Booth S, Kelly MJ, Cox NP, Adams L, Guz A. Does oxygen help dyspnea in patients with cancer? American Journal of Respiratory and Critical Care Medicine. 1996;153(5):1515–1518. [PubMed: 8630595]

Booth S, Wade R, Johnson M, Kite S, Swannick M, Anderson H, et al. The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respiratory Medicine. 2004;98(1):66–77. [PubMed: 14959816]

Bradby H, Kenten C, Deedat S, Morgan M. Having a different conversation around death: Diverse hospital chaplains' views on end-of-life care. Ethnicity and Health. 2013;18(6):530–543. [PubMed: 23998354]

Brandt HE, Deliens L, Ooms ME, van der Steen JT, van der Wal G, Ribbe MW. Symptoms, signs, problems, and diseases of terminally ill nursing home patients: a nationwide observational study in the Netherlands. Archives of Internal Medicine. 2005;165(3):314–320. [PubMed: 15710795]

Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. American Journal of Psychiatry. 1996;153(2):231–237. [PubMed: 8561204]

Brescia FJ. A study of controlled-release oral morphine (MS Contin) in an advanced cancer hospital. Journal of Pain and Symptom Management. 1987;2(4):193–198. [PubMed: 2444659]

Broom A, Kirby E, Good P, Wootton J, Adams J. The troubles of telling: managing communication about the end of life. Qualitative Health Research. 2014;24(2):151–162. [PubMed: 24469692]

Bruera E, Belzile M, Neumann C, Harsanyi Z, Babul N, Darke A. A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. Journal of Pain and Symptom Management. 2000;19(6):427–435. [PubMed: 10908823]

Bruera E, de Stoutz N, Velasco-Leiva A, Schoeller T, Hanson J. Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patients. The Lancet. 1993;342(8862):13–14. [PubMed: 8100289]

Bruera E, Hui D, Dalal S, Torres-Vigil I, Trumble J, Roosth J, et al. Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2013;31(1):111–118. [PMC free article: PMC3530688] [PubMed: 23169523]

Bruera E, Maceachern T, Ripamonti C, Hanson J. Subcutaneous morphine for dyspnea in cancer patients. Annals of Internal Medicine. 1993;119(9):906–907. [PubMed: 8215003]

Bruera E, Macmillan K, Pither J, MacDonald RN. Effects of morphine on the dyspnea of terminal cancer patients. Journal of Pain and Symptom Management. 1990;5(6):341–344. [PubMed: 2269800]

Bruera E, Neumann CM, Mazzocato C, Stiefel F, Sala R. Attitudes and beliefs of palliative care physicians regarding communication with terminally ill cancer patients. Palliative Medicine. 2000;14(4):287–298. [PubMed: 10974980]

Bruera E, Roca E, Cedaro L, Carraro S, Chacon R. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treatment Reports. 1985;69(7-8):751–754. [PubMed: 2410117]

Bruera E, Sala R, Rico MA, Moyano J, Centeno C, Willey J, et al. Effects of parenteral hydration in terminally ill cancer patients: a preliminary study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2005;23(10):2366–2371. [PubMed: 15800328]

Bruera E, Schoeller T, Maceachern T. Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: the use of the N of 1 randomized controlled trial. Journal of Pain and Symptom Management. 1992;7(6):365–368. [PubMed: 1517652]

Bruera E, Sweeney C, Willey J, Palmer JL, Strasser F, Morice RC, et al. A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea. Palliative Medicine. 2003;17(8):659–663. [PubMed: 14694916]

Bush SH, Kanji S, Pereira JL, Davis DHJ, Currow DC, Meagher DJ, et al. Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development. Journal of Pain and Symptom Management. 2014;48(2):231–248. [PMC free article: PMC4081457] [PubMed: 24480529]

Butler C, Holdsworth L. Setting up a new evidence-based hospice-at-home service in England. International Journal of Palliative Nursing. 2013;19(7):355–359. [PubMed: 24273813]

Butow P, Tattersall M. Communication about prognosis and end of life issues. Psycho-Oncology. 2014;23

CADTH. Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines. Canada. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH); 2014. Available from: http://www​.cadth.ca/media​/pdf/htis/jun-2014​/RB0685%20Fentanyl​%20Transdermal%20Patch%20Final.pdf.

Campbell ML. Dyspnea prevalence, trajectories, and measurement in critical care and at life's end. Current Opinion in Supportive and Palliative Care. 2012;6(2):168–171. [PubMed: 22469665]

Campbell ML, Yarandi H, Dove-Medows E. Oxygen is nonbeneficial for most patients who are near death. Journal of Pain and Symptom Management. 2013;45(3):517–523. [PubMed: 22921175]

Campbell ML, Yarandi HN. Death rattle is not associated with patient respiratory distress: is pharmacologic treatment indicated? Journal of Palliative Medicine. 2013;16(10):1255–1259. [PubMed: 24047451]

Candy B, Jackson KC, Jones L, Leurent B, Tookman A, King M. Drug therapy for delirium in terminally ill adult patients. John Wiley & Sons, Ltd.; Cochrane Database of Systematic Reviews. 2012;(11):1–18. [PubMed: 23152226]

Candy B, Jackson KC, Jones L, Tookman A, King M. Drug therapy for symptoms associated with anxiety in adult palliative care patients. John Wiley & Sons, Ltd.; Cochrane Database of Systematic Reviews. 2012;(10):1–20. [PubMed: 23076905]

Caron CD, Griffith J, Arcand M. Decision making at the end of life in dementia: How family caregivers perceive their interactions with health care providers in long-term-care settings. Journal of Applied Gerontology. 2005;24(3):231–247.

Caron CD, Griffith J, Arcand M. End-of-life decision making in dementia: the perspective of family caregivers. Dementia (14713012). 2005;4(1):113–136.

Casscells W, Vasseghi MF, Siadaty MS, Madjid M, Siddiqui H, Lal B, et al. Hypothermia is a bedside predictor of imminent death in patients with congestive heart failure. American Heart Journal. 2005;149(5):927–933. [PubMed: 15894979]

Cerchietti L, Navigante A, Sauri A, Palazzo F. Hypodermoclysis for control of dehydration in terminal-stage cancer. International Journal of Palliative Nursing. 2000;6(8):370–374. [PubMed: 12411847]

Chan KY, Li CW, Wong H, Yip T, Chan ML, Cheng HW, et al. Use of sertraline for antihistamine-refractory uremic pruritus in renal palliative care patients. Journal of Palliative Medicine. 2013;16(8):966–970. [PubMed: 23777329]

Chapman L, Ellershaw J. Care in the last hours and days of life. Medicine. 2011;39(11):674–677.

Charles MA, Reymond L, Israel F. Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline. Journal of Pain and Symptom Management. 2008;36(1):29–38. [PubMed: 18358689]

Cheng JWM, Nayar M. A review of heart failure management in the elderly population. American Journal Geriatric Pharmacotherapy. 2009;7(5):233–249. [PubMed: 19948300]

Cherlin E, Fried T, Prigerson HG, Schulman-Green D, Johnson-Hurzeler R, Bradley EH. Communication between physicians and family caregivers about care at the end of life: when do discussions occur and what is said? Journal of Palliative Medicine. 2005;8(6):1176–1185. [PMC free article: PMC1459281] [PubMed: 16351531]

Chew JRY. Oxygen therapy is equivalent to room air for alleviating refractory dyspnoea. Thorax. 2011;66(8):685–686.

Chiang JK, Lai NS, Wang MH, Chen SC, Kao YH. A proposed prognostic 7-day survival formula for patients with terminal cancer. BMC Public Health. 2009;9:365. [PMC free article: PMC2761894] [PubMed: 19785768]

Christakis NA, Lamont EB. Extent and determinants of error in physicians' prognoses in terminally ill patients: prospective cohort study. Western Journal of Medicine. 2000;172(5):310–313. [PMC free article: PMC1070876] [PubMed: 18751282]

Clark K, Currow DC, Agar M, Fazekas BS, Abernethy AP. A pilot phase II randomized, cross-over, double-blinded, controlled efficacy study of octreotide versus hyoscine hydrobromide for control of noisy breathing at the end-of-life. Journal of Pain and Palliative Care Pharmacotherapy. 2008;22(2):131–138. [PubMed: 19042837]

Clark K, Agar MR, Currow D. Metoclopramide for chronic nausea in adult palliative care patients with advanced cancer. Cochrane Database of Systematic Reviews. 2013;(11) CD008387. [CrossRef]

Clark K, Butler M. Noisy respiratory secretions at the end of life. Current Opinion in Supportive and Palliative Care. 2009;3(2):120–124. [PubMed: 19333125]

Clarke A, Ross H. Influences on nurses' communications with older people at the end of life: perceptions and experiences of nurses working in palliative care and general medicine. International Journal of Older People Nursing. 2006;1(1):34–43. [PubMed: 20925726]

Clary PL, Lawson P. Pharmacologic pearls for end-of-life care. American Family Physician. 2009;79(12):1059–1065. [PubMed: 19530636]

Clayton JM, Butow PN, Arnold RM, Tattersall MHN. Discussing end-of-life issues with terminally ill cancer patients and their carers: a qualitative study. Supportive Care in Cancer. 2005;13(8) [PubMed: 15645187]

Clayton JM, Butow PN, Tattersall MHN. The needs of terminally ill cancer patients versus those of caregivers for information regarding prognosis and end-of-life issues. Cancer. 2005;103(9):1957–1964. [PubMed: 15789363]

Clemens KE, Klaschik E. Dyspnoea associated with anxiety--symptomatic therapy with opioids in combination with lorazepam and its effect on ventilation in palliative care patients. Supportive Care in Cancer. 2011;19(12):2027–2033. [PubMed: 21153667]

Clemens KE, Quednau I, Klaschik E. Bowel function during pain therapy with oxycodone/naloxone prolonged-release tablets in patients with advanced cancer. International Journal of Clinical Practice. 2011;65(4):472–478. [PubMed: 21401835]

Clemens KE, Quednau I, laschik E. Use of oxygen and opioids in the palliation of dyspnoea in hypoxic and non-hypoxic palliative care patients: a prospective study. Supportive Care in Cancer. 2009;17(4):367–377. [PubMed: 18719948]

Clover A, Browne J, McErlain P, Vandenberg B. Patient approaches to clinical conversations in the palliative care setting. Journal of Advanced Nursing. 2004;48(4):333–341. [PubMed: 15500527]

Cobb JL, Glantz MJ, Nicholas PK, Martin EW, Paul-Simon A, Cole BF, et al. Delirium in patients with cancer at the end of life. Cancer Practice. 2000;8(4):172–177. [PubMed: 11898256]

Commercial Medicines Unit (CMU); Department of Health. Electronic market information tool (EMIT). 2014. [1 August 2011]. Available from: http://cmu​.dh.gov.uk​/electronic-market-information-tool-emit/

Conboy-Hill S. Psychosocial aspects of terminal care. A preliminary study of nurses' attitudes and behaviour in a general hospital. International Nursing Review. 1986;33(1):19–21. [PubMed: 3632955]

Conill C, Verger E, Henriquez I, Saiz N, Espier M, Lugo F, et al. Symptom prevalence in the last week of life. Journal of Pain and Symptom Management. 1997;14(6):328–331. [PubMed: 9409097]

Considine J, Miller K. The dialectics of care: communicative choices at the end of life. Health Communication. 2010;25(2):165–174. [PubMed: 20390682]

Corli O, Cozzolino A, Battaiotto L. Effectiveness of levosulpiride versus metoclopramide for nausea and vomiting in advanced cancer patients: a double-blind, randomized, crossover study. Journal of Pain and Symptom Management. 1995;10(7):521–526. [PubMed: 8537694]

Coyne PJ, Viswanathan R, Smith TJ. Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea. Journal of Pain and Symptom Management. 2002;23(2):157–160. [PubMed: 11844637]

Cranston JM, Crockett A, Currow D. Oxygen therapy for dyspnoea in adults. Cochrane Database of Systematic Reviews. 2008;(3) CD004769. [PubMed: 18646110]

Crawford A. Respiratory practitioners' experience of end-of-life discussions in COPD. British Journal of Nursing. 2010;19(18):1164–1169. [PubMed: 20948471]

Csikai EL. Bereaved hospice caregivers' perceptions of the end-of-life care communication process and the involvement of health care professionals. Journal of Palliative Medicine. 2006;9(6):1300–1309. [PubMed: 17187538]

Cuervo Pinna MA, Mota Vargas R, Redondo Moralo MJ, Sanchez Correas MA, Pera Blanco G. Dyspnea--a bad prognosis symptom at the end of life. American Journal of Hospice and Palliative Care. 2009;26(2):89–97. [PubMed: 19114605]

Currow DC, Agar M, Smith J, Abernethy AP. Does palliative home oxygen improve dyspnoea? A consecutive cohort study. Palliative Medicine. 2009;23(4):309–316. [PubMed: 19304806]

Currow DC, Quinn S, Agar M, McCaffrey HJ. Double-Blind, Placebo-Controlled, Randomized Trial of Octreotide in Malignant Bowel Obstruction. Journal of Pain and Symptom Management. 2014;49(5):814–821. [PubMed: 25462210]

Currow DC, Smith J, Davidson PM, Newton PJ, Agar MR, Abernethy AP. Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study. Journal of Pain and Symptom Management. 2010;39(4):680–690. [PubMed: 20413056]

Curtis JR, Engelberg RA, Nielsen EL, Au DH, Patrick DL. Patient-physician communication about end-of-life care for patients with severe COPD. European Respiratory Journal. 2004;24(2):200–205. [PubMed: 15332385]

Curtis JR, Patrick DL. Barriers to communication about end-of-life care in AIDS patients. Journal of General Internal Medicine. 1997;12(12):736–741. [PMC free article: PMC1497199] [PubMed: 9436892]

Curtis JR, Patrick DL, Caldwell E, Greenlee H, Collier AC. The quality of patient-doctor communication about end-of-life care: a study of patients with advanced AIDS and their primary care clinicians. AIDS. 1999;13(9):1123–1131. [PubMed: 10397544]

Curtis JR, Patrick DL, Caldwell ES, Collier AC. Why don't patients and physicians talk about end-of-life care? Barriers to communication for patients with acquired immunodeficiency syndrome and their primary care clinicians. Archives of Internal Medicine. 2000;160(11):1690–1696. [PubMed: 10847263]

Curtis JR, Engelberg R, Young JP, Vig LK, Reinke LF, Wenrich MD, et al. An approach to understanding the interaction of hope and desire for explicit prognostic information among individuals with severe chronic obstructive pulmonary disease or advanced cancer. Journal of Palliative Medicine. 2008;11(4):610–620. [PubMed: 18454614]

Dale O, Moksnes K, Kaasa S. European Palliative Care Research Collaborative pain guidelines: opioid switching to improve analgesia or reduce side effects. A systematic review. Palliative Medicine. 2011;25(5):494–503. [PubMed: 21708856]

Danoff SK, Schonhoft EH. Role of support measures and palliative care. Current Opinion in Pulmonary Medicine. 2013;19(5):480–484. [PubMed: 23880699]

Darvill E, Dorman S, Perkins P. Levomepromazine for nausea and vomiting in palliative care. Cochrane Database of Systematic Reviews. 2013;(4) CD009420. [PubMed: 23633372] [CrossRef]

Daud ML. Drug management of terminal symptoms in advanced cancer patients. Current Opinion in Supportive and Palliative Care. 2007;1(3):202–206. [PubMed: 18685364]

Davis MP, Khawam E, Pozuelo L, Lagman R. Management of symptoms associated with advanced cancer: olanzapine and mirtazapine. A World Health Organization project. Expert Review of Anticancer Therapy. 2002;2(4):365–376. [PubMed: 12647979]

Dean A. The palliative effects of octreotide in cancer patients. Chemotherapy. 2001;47(Suppl 2):54–61. [PubMed: 11275702]

Dendaas NR. Prognostication in advance cancer: nurses' perceptions of the dying process. Oncology Nursing Forum. 2002;29(3):493–499. [PubMed: 11979282]

Dietz I, Schmitz A, Lampey I, Schulz C. Evidence for the use of Levomepromazine for symptom control in the palliative care setting: a systematic review. BMC Palliative Care. 2013;12:2. [PMC free article: PMC3602665] [PubMed: 23331515]

Domeisen BF, Ostgathe C, Clark J, Costantini M, Daud ML, Grossenbacher-Gschwend B, et al. International palliative care experts' view on phenomena indicating the last hours and days of life. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 2013;21(6):1509–1517. [PubMed: 23242388]

Dorman S, Perkins P. Droperidol for treatment of nausea and vomiting in palliative care patients. Cochrane Database of Systematic Reviews. 2010;(10)(6) CD006938. [PubMed: 20927752] [CrossRef]

Douglas C, Murtagh FEM, Chambers EJ, Howse M, Ellershaw J. Symptom management for the adult patient dying with advanced chronic kidney disease: a review of the literature and development of evidence-based guidelines by a United Kingdom Expert Consensus Group. Palliative Medicine. 2009;23(2):103–110. [PubMed: 19273566]

Downing GM, Lynd PJ, Gallagher R, Hoens A. Challenges in understanding functional decline, prognosis, and transitions in advanced illness: dilemmas at the end of life. Topics in Geriatric Rehabilitation. 2011;27(1):18–28.

Dudgeon DJ, Bruera E, Gagnon B, Watanabe SM, Allan SJ, Warr DG, et al. A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients. Journal of Pain and Symptom Management. 2007;33(4):365–371. [PubMed: 17397698]

Dunn GP, Milch RA. Is this a bad day, or one of the last days? How to recognize and respond to approaching demise. Journal of the American College of Surgeons. 2002;195(6):879–887. [PubMed: 12495320]

Dunning T, Savage S, Duggan N, Martin P. Developing clinical guidelines for end-of-life care: blending evidence and consensus. International Journal of Palliative Nursing. 2012;18(8):397–405. [PubMed: 23123985]

Eaton B, Hall J, MacDonald S. Does nebulized morphine offer symptom relief to patients with disabling dyspnea during end-stage disease? Canadian Family Physician. 1999 FEB;45:319–320. [PMC free article: PMC2328270] [PubMed: 10065305]

Eisenchlas JH, Garrigue N, Junin M, De Simone GG. Low-dose levomepromazine in refractory emesis in advanced cancer patients: An open-label study. Palliative Medicine. 2005;19(1):71–75. [PubMed: 15690871]

El-Sahwi KS, Illuzzi J, Varughese J, Carusillo N, Ratner ES, Silasi DA, et al. A survey of gynecologic oncologists regarding the end-of-life discussion: a pilot study. Gynecologic Oncology. 2012;124(3):471–473. [PubMed: 22014628]

Ellershaw JE, Sutcliffe JM, Saunders CM. Dehydration and the dying patient. Journal of Pain and Symptom Management. 1995;10(3):192–197. [PubMed: 7629413]

Emanuel L, Alexander C, Arnold RM, Bernstein R, Dart R, Dellasantina C, et al. Integrating palliative care into disease management guidelines. Journal of Palliative Medicine. 2004;7(6):774–783. [PubMed: 15684844]

Endacott R, De Keyser GF, Benbenishty J, Ben NM, Ryan H, Chamberlain W, et al. Timing, content and impact of end of life discussions with patients and families in ICU: Perspectives from israel and the uk. Intensive Care Medicine. 2013;39

Enguidanos S, Housen P, Penido M, Mejia B, Miller JA. Family members' perceptions of inpatient palliative care consult services: a qualitative study. Palliative Medicine. 2014;28(1) [PubMed: 23744841]

Escalante CP, Martin CG, Elting LS, Price KJ, Manzullo EF, Weiser MA, et al. Identifying risk factors for imminent death in cancer patients with acute dyspnea. Journal of Pain and Symptom Management. 2000;20(5):318–325. [PubMed: 11068153]

Evans LR, Boyd EA, Malvar G, Apatira L, Luce JM, Lo B, et al. Surrogate decision-makers' perspectives on discussing prognosis in the face of uncertainty. American Journal of Respiratory and Critical Care Medicine. 2009;179(1) [PMC free article: PMC2615661] [PubMed: 18931332]

Evans N, Costantini M, Pasman HR, Van den Block L, Donker GA, Miccinesi G, et al. End-of-life communication: a retrospective survey of representative general practitioner networks in four countries. Journal of Pain and Symptom Management. 2014;47(3):604–619. [PubMed: 23932176]

Evans N, Pasman HR, Payne SA, Seymour J, Pleschberger S, Deschepper R, et al. Older patients' attitudes towards and experiences of patient-physician end-of-life communication: a secondary analysis of interviews from British, Dutch and Belgian patients. BMC Palliative Care. 2012;11 [PMC free article: PMC3583811] [PubMed: 23186392]

Exline JJ, Prince-Paul M, Root BL, Peereboom KS, Worthington ELJ. Forgiveness, depressive symptoms, and communication at the end of life: a study with family members of hospice patients. Journal of Palliative Medicine. 2012;15(10) [PubMed: 22849437]

Fainsinger R, Miller MJ, Bruera E, Hanson J, Maceachern T. Symptom control during the last week of life on a palliative care unit. Journal of Palliative Care. 1991;7(1):5–11. [PubMed: 2045996]

Fantoni M, Ricci F, Del Borgo C, Bevilacqua N, Izzi I, Damiano F, et al. Symptom profile in terminally ill AIDS patients. AIDS Patient Care and STDs. 1996;10(3):171–173. [PubMed: 11361618]

Faull C, Windridge K, Ockleford E, Hudson M. Anticipatory prescribing in terminal care at home: what challenges do community health professionals encounter? BMJ Supportive and Palliative Care. 2013;3(1):91–97. [PubMed: 24644333]

Feliu J, Jimenez-Gordo AM, Madero R, Rodriguez-Aizcorbe JR, Espinosa E, Castro J, et al. Development and validation of a prognostic nomogram for terminally ill cancer patients. Journal of the National Cancer Institute. 2011;103(21):1613–1620. [PubMed: 21972226]

Feuer David DJ, Broadley KE. Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database of Systematic Reviews. 1999;(3) CD001219. [PMC free article: PMC6481479] [PubMed: 10796761] [CrossRef]

Fields A, Finucane AM, Oxenham D. Discussing preferred place of death with patients: staff experiences in a UK specialist palliative care setting. International Journal of Palliative Nursing. 2013;19(11):558–565. [PubMed: 24263900]

Finucane AM, Stevenson B, Gardner H, McArthur D, Murray SA. Anticipatory prescribing at the end of life in Lothian care homes. British Journal of Community Nursing. 2014;19(11):544–547. [PubMed: 25381850]

Flume PA. Medicinal treatment of intractable dyspnea in terminally ill patients. Journal of the South Carolina Medical Association. 2002;98(4):196–199. [PubMed: 12216382]

Fordyce M. At the end of life. Annals of Long-Term Care. 2001;9(3):80.

Fortinsky RH, Downs M. Optimizing person-centered transitions in the dementia journey: A comparison of national dementia strategies. Health Affairs. 2014;33(4):566–573. [PubMed: 24711316]

Fowell A, Russell I, Johnstone R, Finlay I, Russell D. Cluster randomisation or randomised consent as an appropriate methodology for trials in palliative care: A feasibility study ISRCTN60243484. BMC Palliative Care. 2004;3:1–7. [PMC free article: PMC420454] [PubMed: 15113420]

Frank C. Medical management of intestinal obstruction in terminal care. Canadian Family Physician Medecin De Famille Canadien. 1997;43:259–265. [PMC free article: PMC2255220] [PubMed: 9040913]

Friedrichsen MJ, Strang PM, Carlsson ME. Breaking bad news in the transition from curative to palliative cancer care--patient's view of the doctor giving the information. Supportive Care in Cancer. 2000;8(6) [PubMed: 11094992]

Fritzson A, Tavelin B, Axelsson B. Association between parenteral fluids and symptoms in hospital end-of-life care: an observational study of 280 patients. BMJ Supportive and Palliative Care. 2013 [PubMed: 24644196]

Fromme EK, Tilden VP, Drach LL, Tolle SW. Increased family reports of pain or distress in dying Oregonians: 1996 to 2002. Journal of Palliative Medicine. 2004;7(3):431–442. [PubMed: 15265353]

Furst CJ, Lindqvist O, Tishelman C. Towards a basic drug kit for the dying patient. Current Opinion in Supportive and Palliative Care. 2012;6(3):386–390. [PubMed: 22801469]

Gadoud A, Macleod U, Johnson MJ. The perceptions of patient, carers and healthcare professionals regarding the transition to palliative care in advanced heart failure. Cardiology. 2013;126

Gamborg H, Riis J, Christrup L, Krantz T. Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases. Journal of Opioid Management. 2013;9(4):269–274. [PubMed: 24353020]

Ganzini L. Care of patients with delirium at the end of life. Annals of Long-Term Care. 2007;15(3):35–40.

Generali J, Cada DJ. Furosemide (nebulized): Dyspnea in cancer patients. Hospital Pharmacy. 2004;39(11):1040–1049.

Georges JJ, Onwuteaka-Philipsen BD, van der Heide A, van der Wal G, van der Maas PJ. Symptoms, treatment and “dying peacefully” in terminally ill cancer patients: a prospective study. Supportive Care in Cancer. 2005;13(3):160–168. [PubMed: 15578235]

Gibbins J, McCoubrie R, Alexander N, Kinzel C, Forbes K. Diagnosing dying in the acute hospital setting--are we too late? Clinical Medicine (London, England). 2009;9(2):116–119. [PMC free article: PMC4952659] [PubMed: 19435113]

Gilbertson-White S, Aouizerat BE, Jahan T, Miaskowski C. A review of the literature on multiple symptoms, their predictors, and associated outcomes in patients with advanced cancer. Palliative and Supportive Care. 2011;9(1):81–102. [PubMed: 21352621]

Gilman SA, Banzett RB. Physiologic changes and clinical correlates of advanced dyspnea. Current Opinion in Supportive and Palliative Care. 2009;3(2):93–97. [PMC free article: PMC2834174] [PubMed: 19421065]

Girard TD, Pandharipande PP, Carson SS, Schmidt GA, Wright PE, Canonico AE, et al. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: The MIND randomized, placebo-controlled trial. Critical Care Medicine. 2010;38(2):428–437. [PMC free article: PMC3645269] [PubMed: 20095068]

Glare P, Clark K. Management of a patient with terminal illness: The final stages of life. Medicine Today. 2008;9(6):40–48.

Glare P, Miller J, Nikolova T, Tickoo R. Treating nausea and vomiting in palliative care: a review. Clinical Interventions in Aging. 2011;6:243–259. [PMC free article: PMC3180521] [PubMed: 21966219]

Glare P, Pereira G, Kristjanson LJ, Stockler M, Tattersall M. Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer. Supportive Care in Cancer. 2004;12(6):432–440. [PubMed: 15108099]

Goebel JR, Doering LV, Shugarman LR, Asch SM, Sherbourne CD, Lanto AB, et al. Heart failure: the hidden problem of pain. Journal of Pain and Symptom Management. 2009;38(5):698–707. [PMC free article: PMC2908037] [PubMed: 19733032]

Gomutbutra P, O'Riordan DL, Pantilat SZ. Management of moderate-to-severe dyspnea in hospitalized patients receiving palliative care. Journal of Pain and Symptom Management. 2013;45(5):885–891. [PubMed: 22940561]

Gonzales MJ, Widera E. Nausea and other nonpain symptoms in long-term care. Clinics in Geriatric Medicine. 2011;27(2):213–228. [PubMed: 21641507]

Goodman C, Evans C, Wilcock J, Froggatt K, Drennan V, Sampson E, et al. End of life care for community dwelling older people with dementia: an integrated review. International Journal of Geriatric Psychiatry. 2010;25(4):329–337. [PubMed: 19688739]

Granek L, Krzyzanowska MK, Tozer R, Mazzotta P. Oncologists' strategies and barriers to effective communication about the end of life. Journal of Oncology Practice. 2013;9(4):1–7. [PMC free article: PMC3710179] [PubMed: 23942929]

Grbich C, Parish K, Glaetzer K, Hegarty M, Hammond L, McHugh A. Communication and decision making for patients with end stage diseases in an acute care setting. Contemporary Nurse. 2006;23(1):21–37. [PubMed: 17083317]

Greer DM, Curiale GG. End-of-life and brain death in acute coma and disorders of consciousness. Seminars in Neurology. 2013;33(2):157–166. [PubMed: 23888399]

Griggs C. Community nurses' perceptions of a good death: a qualitative exploratory study. International Journal of Palliative Nursing. 2010;16(3):140–149. [PubMed: 20357707]

Grosset AB, Roberts MS, Woodson ME, Shi M, Swanton RE, Reder RF, et al. Comparative efficacy of oral extended-release hydromorphone and immediate-release hydromorphone in patients with persistent moderate to severe pain: two randomized controlled trials. Journal of Pain and Symptom Management. 2005;29(6):584–594. [PubMed: 15963867]

Gutierrez KM. Experiences and needs of families regarding prognostic communication in an intensive care unit: supporting families at the end of life. Critical Care Nursing Quarterly. 2012;35(3):299–313. [PubMed: 22669004]

Gutierrez KM. Prognostic communication of critical care nurses and physicians at end of life. Dimensions of Critical Care Nursing. 2012;31(170):182. [PubMed: 22475704]

Hack TF, McClement SE, Chochinov HM, Cann BJ, Hassard TH, Kristjanson LJ, et al. Learning from dying patients during their final days: life reflections gleaned from dignity therapy. Palliative Medicine. 2010;24(7):715–723. [PubMed: 20605851]

Hagerty RG, Butow PN, Ellis PA, Lobb ElA, Pendlebury S, Leighl N, et al. Cancer patient preferences for communication of prognosis in the metastatic setting. Journal of Clinical Oncology. 2004;22(9):1721. [PubMed: 15117995]

Hagerty RG, Butow PN, Ellis PM, Lobb EA, Pendlebury SC, Leighl N, et al. Communicating with realism and hope: incurable cancer patients' views on the disclosure of prognosis. Journal of Clinical Oncology. 2005;23(6):1278–1788. [PubMed: 15718326]

Hardy J, Daly S, McQuade B, Albertsson M, Chimontsi-Kypriou V, Stathopoulos P, et al. A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 2002;10(3):231–236. [PubMed: 11904788]

Hardy J, Ling J, Mansi J, Isaacs R, Bliss J, A'Hern R, et al. Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction. Palliative Medicine. 1998;12(6):437–442. [PubMed: 10621863]

Harlow G, Johnston AM. A protocol of no sedation for critically ill patients receiving mechanical ventilation: A randomised trial. Journal of the Intensive Care Society. 2011;12(2):147–148.

Harris DG. Nausea and vomiting in advanced cancer. British Medical Bulletin. 2010;96(1):175–185. [PubMed: 20884654]

Harris DG. Management of pain in advanced disease. British Medical Bulletin. 2014;110(1):117–128. [PubMed: 24810848]

Harris JT, Suresh Kumar K, Rajagopal MR. Intravenous morphine for rapid control of severe cancer pain. Palliative Medicine. 2003;17(3):248–256. [PubMed: 12725478]

Heegaard HB, Glud E. Palliative, non-surgical treatment of malignant bowel obstruction (MBO) in patients with advanced gynecological or gastrointestinal cancer: A pico question-based critical review of the literature. Palliative Medicine. 2014;28(6):704.

Heisler M, Hamilton G, Abbott A, Chengalaram A, Koceja T, Gerkin R. Randomized double-blind trial of sublingual atropine vs. placebo for the management of death rattle. Journal of Pain and Symptom Management. 2013;45(1):14–22. [PubMed: 22795904]

Hendriks SA, Smalbrugge M, Hertogh CMPM, van der Steen JT. Dying with dementia: symptoms, treatment, and quality of life in the last week of life. Journal of Pain and Symptom Management. 2014;47(4):710–720. [PubMed: 23916680]

Herndon CM, Jackson II KC, Hallin PA. Management of opioid-induced gastrointestinal effects in patients receiving palliative care. Pharmacotherapy. 2002;22(2 I):240–250. [PubMed: 11837561]

Hilden HM, Honkasalo ML, Louhiala P. Finnish doctors and the realisation of patient autonomy in the context of end of life decision making. Journal of Medical Ethics. 2006;32(6):316–320. [PMC free article: PMC2563364] [PubMed: 16731727]

Hilden HM, Honkasalo ML. Finnish nurses' interpretations of patient autonomy in the context of end-of-life decision making. Nursing Ethics. 2006;13(1):41–51. [PubMed: 16425903]

Hinkka H, Kosunen E, Kellokumpu-Lehtinen P, Lammi UK. Assessment of pain control in cancer patients during the last week of life: comparison of health centre wards and a hospice. Supportive Care in Cancer. 2001;9(6):428–434. Finland. [PubMed: 11585269]

Hipp B, Letizia MJ. Understanding and responding to the death rattle in dying patients. Medsurg Nursing. 2009;18(1):17–22. [PubMed: 19331295]

Hirakawa Y, Masuda Y, Kuzuya M, Iguchi A, Uemura K. Gender differences in symptom experience at end-of-life among elderly patients dying at home with advanced cancer in Japan. Japan Medical Association Journal. 2006;49(11-12):351–357.

Hirakawa Y, Masuda Y, Kuzuya M, Iguchi A, Uemura K. How elderly people die of nonmalignant pulmonary disease at home. Japan Medical Association Journal. 2006;49(3):106–111.

Hirakawa Y, Masuda Y, Kuzuya M, Iguchi A, Uemura K. Symptoms and care of elderly patients dying at home of lung, gastric, colon, and liver cancer. Japan Medical Association Journal. 2006;49(4):140–145.

Hirakawa Y, Masuda Y, Kuzuya M, Kimata T, Iguchi A, Uemura K. End-of-life experience of demented elderly patients at home: Findings from DEATH project. Psychogeriatrics. 2006;6(2):60–67.

Hirakawa Y, Masuda Y, Kuzuya M, Kimata T, Iguchi A, Uemura K. Symptom experience and patterns of end-of-life - Home care for elderly patients with cancer vs. those without cancer in Japan. Japan Medical Association Journal. 2006;49(7-8):243–250.

Hirsch CA, Marriott JF, Faull CM. Influences on the decision to prescribe or administer anticholinergic drugs to treat death rattle: a focus group study. Palliative Medicine. 2013;27(8):732–738. [PubMed: 23175510]

Hjelmfors A-L, Jaarsma T, Martensson J, Friedrichsen M, Sandgren A, Stromberg A. Discussing prognosis and end-of-life with heart failure patients. European Heart Journal. 2013;34

Hjelmfors L, Jaarsma T, Martensson J, Friedrichsen M, Stromberg A. Communicating prognosis and end-of-life to heart failure patients: Heart failure nurses' perspectives. European Journal of Heart Failure. 2013;12(152):161. [PubMed: 24480779]

Hjelmfors LH, Stromberg AS, Friedrichsen MF, Martensson JM, Jaarsma TJ. Communicating prognosis and end-of-life to heart failure patients. European Journal of Cardiovascular Nursing. 2014;13 [PubMed: 24480779]

Hjelmfors L, Stromberg A, Friedrichsen M, Martensson J, Jaarsma T. Communicating prognosis and end-of-life care to heart failure patients: a survey of heart failure nurses' perspectives. European Journal of Cardiovascular Nursing. 2014;13(2):152–161. [PubMed: 24480779]

Hjorleifsdottir E, Carter DE. Communicating with terminally ill cancer patients and their families. Nurse Education Today. 2000;20(8) [PubMed: 11090312]

Hochgerner M, Fruhwald FM, Strohscheer I. Opioids for symptomatic therapy of dyspnoea in patients with advanced chronic heart failure--is there evidence? Wiener Medizinische Wochenschrift. 2009;159(23-24):577–582. [PubMed: 20151346]

Hofmann JC, Wenger NS, Davis RB, Teno J, Connors J, Desbiens N, et al. Patient preferences for communication with physicians about end-of-life decisions. Annals of Internal Medicine. 1997;127(1):1–12. [PubMed: 9214246]

Houttekier D, Witkamp FE, van Zuylen L, van der Rijt CCD, van der Heide A. Is physician awareness of impending death in hospital related to better communication and medical care? Journal of Palliative Medicine. 2014;17(11):1238–1243. [PubMed: 25115220]

Hsieh HF, Shannon SE, Curtis JR. Contradictions and communication strategies during end-of-life decision making in the intensive care unit. Journal of Critical Care. 2006;21(4):294–304. [PubMed: 17175415]

Huang Y, Xi Q, Xia S, Wang X, Liu Y, Huang C, et al. Development and validation of a prognostic scale for hospitalized patients with terminally ill cancer in China. Supportive Care in Cancer. 2014;22(1):145–152. [PubMed: 24013570]

Hugel H, Ellershaw J, Gambles M. Respiratory tract secretions in the dying patient: a comparison between glycopyrronium and hyoscine hydrobromide. Journal of Palliative Medicine. 2006;9(2):279–284. [PubMed: 16629557]

Hughes A, Wilcock A, Corcoran R, Lucas V, King A. Audit of three antimuscarinic drugs for managing retained secretions. Palliative Medicine. 2000;14(3):221–222. [PubMed: 10858832]

Hui D, dos Santos R, Chisholm G, Bansal S, Silva TB, Kilgore K, et al. Clinical signs of impending death in cancer patients. Oncologist. 2014;19(6):681–687. [PMC free article: PMC4041673] [PubMed: 24760709]

Hui D, Morgado M, Chisholm G, Withers L, Nguyen Q, Finch C, et al. High-flow oxygen and bilevel positive airway pressure for persistent dyspnea in patients with advanced cancer: a phase II randomized trial. Journal of Pain and Symptom Management. 2013;46(4):463–473. [PMC free article: PMC3795985] [PubMed: 23739633]

Hunt R, Fazekas B, Thorne D, Brooksbank M. A comparison of subcutaneous morphine and fentanyl in hospice cancer patients. Journal of Pain and Symptom Management. 1999;18(2):111–119. [PubMed: 10484858]

Husic S, Ljuca D. Cancer pain: Comparison of oral morphine and transdermal fentanyl treatment. Acta Medica Saliniana. 2011;40(1):7–12.

Hussain J, Adams D, Allgar V, Campbell C. Triggers in advanced neurological conditions: prediction and management of the terminal phase. BMJ Supportive and Palliative Care. 2014;4(1):30–37. [PubMed: 24644768]

Imanaka K, Tominaga Y, Etropolski M, Hove I, Ohsaka M, Wanibe M, et al. Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain. Current Medical Research and Opinion. 2013;29(10):1399–1409. [PubMed: 23937387]

Israel FJ, Parker G, Charles M, Reymond L. Lack of benefit from paracetamol (acetaminophen) for palliative cancer patients requiring high-dose strong opioids: a randomized, double-blind, placebo-controlled, crossover trial. Journal of Pain and Symptom Management. 2010;39(3):548–554. [PubMed: 20083373]

Jack BA, Baldry CR, Groves KE, Whelan A, Sephton J, Gaunt K. Supporting home care for the dying: an evaluation of healthcare professionals' perspectives of an individually tailored hospice at home service. Journal of Clinical Nursing. 2013;22(19-20):2778–2786. [PubMed: 23600967]

Jackson A, Purkis J, Burnham E, Hundt GL, Blaxter L. Views of relatives, carers and staff on end of life care pathways. Emergency Nurse : the Journal of the RCN Accident and Emergency Nursing Association. 2010;17(10):22–26. [PubMed: 20364781]

Jackson J, White P, Fiorini J, Shay J, Derderian L, Ayotte J, et al. Family perspectives on end-of-life care: a metasynthesis. Journal of Hospice & Palliative Nursing. 2012;14(4)

Jackson KC, Lipman AG. Drug therapy for delirium in terminally ill patients. Cochrane Database of Systematic Reviews. 2004;(2) CD004770. [PubMed: 15106261]

Janssen DJA, Curtis JR, Au DH, Spruit MA, Downey L, Schols JMGA, et al. Patient-clinician communication about end-of-life care for Dutch and US patients with COPD. European Respiratory Journal. 2011;38(2) [PubMed: 21233263]

Janssen DJA, Spruit MA, Wouters EFM, Schols JMGA. Daily symptom burden in end-stage chronic organ failure: a systematic review. Palliative Medicine. 2008;22(8):938–948. [PubMed: 18801874]

Jennings AL, Davies AN, Higgins JP, Broadley K. Opioids for the palliation of breathlessness in terminal illness. Cochrane Database Syst Rev. 2001;(4) CD002066. [PubMed: 11687137]

Jennings AL, Davies AN, Higgins JP, Robbins RA. Review: Oral parenteral opioids alleviate dyspnoea in palliative care. Evidence-Based Medicine. 2003;8(3):75.

Jensen HI, Ammentorp J, Johannessen H, Ording H. Challenges in end-of-life decisions in the intensive care unit: an ethical perspective. Journal of Bioethical Inquiry. 2013;10(1):93–101. [PubMed: 23299401]

Johnson DC, Kutner JS, Armstrong JD. Would you be surprised if this patient died?: Preliminary exploration of first and second year residents' approach to care decisions in critically ill patients. BMC Palliative Care. 2003;2(1):1. [PMC free article: PMC149224] [PubMed: 12529181]

Johnson JR, Lossignol D, Burnell-Nugent M, Fallon MT. An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. Journal of Pain and Symptom Management. 2013;46(2):207–218. [PubMed: 23141881]

Joint Formulary Committee. British National Formulary (BNF). 66th edition. London: British Medical Association and The Royal Pharmaceutical Society of Great Britain; 2013. Available from: http://www​.bnf.org.uk.

Kai I, Ohi G, Yano E, Kobayashi Y, Miyama T, Niino N, et al. Communication between patients and physicians about terminal care: a survey in Japan. Social Science and Medicine. 1993;36(9) [PubMed: 8511644]

Kallet RH. The role of inhaled opioids and furosemide for the treatment of dyspnea. Respiratory Care. 2007;52(7):900–910. [PubMed: 17594733]

Kamboj SK, Conroy L, Tookman A, Carroll E, Jones L, Curran HV. Effects of immediate-release opioid on memory functioning: A randomized-controlled study in patients receiving sustained-release opioids. European Journal of Pain. 2014;18(10):1376–1384. [PubMed: 24700581]

Kamboj SK, Tookman A, Jones L, Curran HV. The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care. Pain. 2005;117(3):388–395. [PubMed: 16198201]

Kao YH, Chen CN, Chiang JK, Chen SS, Huang WW. Predicting factors in the last week of survival in elderly patients with terminal cancer: a prospective study in southern Taiwan. Journal of the Formosan Medical Association. 2009;108(3):231–239. [PubMed: 19293039]

Kaplowitz SA, Campo S, Chiu WT. Cancer patients' desires for communication of prognosis information. Health Communication. 2002;14(2) [PubMed: 12046799]

Kass RM, Ellershaw J. Respiratory tract secretions in the dying patient: a retrospective study. Journal of Pain and Symptom Management. 2003;26(4):897–902. [PubMed: 14527758]

Keeley PW. Delirium at the end of life. Clinical Evidence. 2009;2009 [PMC free article: PMC2907814] [PubMed: 21696645]

Kehl KA, Kowalkowski JA. A systematic review of the prevalence of signs of impending death and symptoms in the last 2 weeks of life. American Journal of Hospice and Palliative Care. 2013;30(6):601–616. [PubMed: 23236090]

Kehl KA. Treatment of terminal restlessness: a review of the evidence. Journal of Pain and Palliative Care Pharmacotherapy. 2004;18(1):5–30. [PubMed: 15148006]

Kennedy C, Brooks-Young P, Brunton GC, Larkin P, Connolly M, Wilde-Larsson B, et al. Diagnosing dying: an integrative literature review. BMJ Support Palliat Care. 2014 [PMC free article: PMC4145438] [PubMed: 24780536]

Kestenbaum MG, Vilches AO, Messersmith S, Connor SR, Fine PG, Murphy B, et al. Alternative Routes to Oral Opioid Administration in Palliative Care: A Review and Clinical Summary. Pain Medicine. 2014;15(7):1129–1153. [PubMed: 24995406]

King S, Forbes K, Hanks GW, Ferro CJ, Chambers EJ. A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project. Palliative Medicine. 2011;25(5):525–552. [PubMed: 21708859]

King SJ, Reid C, Forbes K, Hanks G. A systematic review of oxycodone in the management of cancer pain. Palliative Medicine. 2011;25(5):454–470. [PubMed: 21708852]

Kintzel PE, Chase SL, Thomas W, Vancamp DM, Clements EA. Anticholinergic medications for managing noisy respirations in adult hospice patients. American Journal of Health-System Pharmacy. 2009;66(5):458–464. [PubMed: 19233993]

Klindtworth K, Pestinger M, Hager K, Oster P, Schneider N. Older patients with advanced heart failure at the end of life: Contrasting cases to explore communication about illness and prognosis. Palliative Medicine. 2012;26(4)

Klinkenberg M, Smit JH, Deeg DJH, Willems DL, Onwuteaka-Philipsen BD, van der Wal G. Proxy reporting in after-death interviews: the use of proxy respondents in retrospective assessment of chronic diseases and symptom burden in the terminal phase of life. Palliative Medicine. 2003;17(2):191–201. [PubMed: 12701851]

Kompanje EJO. “The death rattle” in the intensive care unit after withdrawal of mechanical ventilation in neurological patients. Neurocritical Care. 2005;3(2):107–110. [PubMed: 16174877]

Kozar P, Chatterjee K. Competing discourses surrounding primary caregivers of hospice patients. Journal of Health Care Chaplaincy. 2014;20(4) [PubMed: 25255146]

Kripp M, Willer A, Schmidt C, Pilz LR, Gencer D, Buchheidt D, et al. Patients with malignant hematological disorders treated on a palliative care unit: prognostic impact of clinical factors. Annals of Hematology. 2014;93(2):317–325. [PubMed: 23925929]

Kumagai Y, Maekawa A, Abe M. Prognostic items for the last 10 and 3 days of life of cancer patients at home. Cancer Nursing. 2012;35(5):390–396. [PubMed: 22067697]

Kurita GP, Kaasa S, Sjogren P., European Palliative Care Research Collaborative (EPCRC). Spinal opioids in adult patients with cancer pain: a systematic review: a European Palliative Care Research Collaborative (EPCRC) opioid guidelines project. Palliative Medicine. 2011;25(5):560–577. [PubMed: 21708860]

Kutner JS, Kassner CT, Nowels DE. Symptom burden at the end of life: Hospice providers' perceptions. Journal of Pain and Symptom Management. 2001;21(6):473–480. [PubMed: 11397605]

Kutner JS, Bryant LL, Beaty BL, Fairclough DL. Time course and characteristics of symptom distress and quality of life at the end of life. Journal of Pain and Symptom Management. 2007;34(3):227–236. [PubMed: 17572055]

Laugsand EA, Kaasa S, Klepstad P. Management of opioid-induced nausea and vomiting in cancer patients: Systematic review and evidence-based recommendations. Palliative Medicine. 2011;25(5):442–453. [PubMed: 21708851]

Lauretti GR, Gomes JMA, Reis MP, Pereira NL. Low doses of epidural ketamine or neostigmine, but not midazolam, improve morphine analgesia in epidural terminal cancer pain therapy. Journal of Clinical Anesthesia. 1999;11(8):663–668. [PubMed: 10680109]

Laval G, Girardier J, Lassauniere JM, Leduc B, Haond C, Schaerer R. The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: do they remove the obstruction? Palliative Medicine. 2000;14(1):3–10. [PubMed: 10717717]

Laval G, Rousselot H, Toussaint-Martel S, Mayer F, Terrebonne E, François E, et al. SALTO: a randomized, multicenter study assessing octreotide LAR in inoperable bowel obstruction. Bulletin Du Cancer. 2012;99(2):E1–E9. [PubMed: 22265994]

Lawrence M, Repede E. The incidence of deathbed communications and their impact on the dying process. American Journal of Hospice and Palliative Care. 2013;30(7) [PubMed: 23236088]

Lawton S, Denholm M, Macaulay L, Grant E, Davie A. Timely symptom management at end of life using ‘just in case’ boxes. British Journal of Community Nursing. 2012;17(4):182. -assim. [PubMed: 22848942]

Leak A, Mayer DK, Wyss A, Travers D, Waller A. Why do cancer patients die in the emergency department?: an analysis of 283 deaths in NC EDs. American Journal of Hospice and Palliative Care. 2013;30(2):178–182. [PMC free article: PMC3804064] [PubMed: 22556288]

LeBlanc TW, Abernethy AP. Building the palliative care evidence base: Lessons from a randomized controlled trial of oxygen vs room air for refractory dyspnea. Journal of the National Comprehensive Cancer Network. 2014;12(7):989–992. [PMC free article: PMC4158402] [PubMed: 24994919]

LeBon B, Zeppetella G, Higginson IJ. Effectiveness of topical administration of opioids in palliative care: a systematic review. Journal of Pain and Symptom Management. 2009;37(5):913–917. [PubMed: 19321297]

Lee SF, Kristjanson LJ, Williams AM. Professional relationships in palliative care decision making. Supportive Care in Cancer. 2009;17(4):445–450. [PubMed: 18987900]

Lee YJ, Suh S-Y, Choi YS, Shim JY, Seo A-R, Choi S-E, et al. EORTC QLQ-C15-PAL quality of life score as a prognostic indicator of survival in patients with far advanced cancer. Supportive Care in Cancer. 2014;22(7):1941–1948. [PubMed: 24577883]

Legge J, Ball N, Elliott DP. The potential role of ketamine in hospice analgesia: a literature review. Consultant Pharmacist. 2006;21(1):51–57. [PubMed: 16524352]

LennernAs B, Frank-Lissbrant I, LennernAs H, KAlkner KM, Derrick R, Howell J. Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: Results from a randomized phase II study. Palliative Medicine. 2010;24(3):286–293. [PubMed: 20015921]

Levenson JW, McCarthy EP, Lynn J, Davis RB, Phillips RS. The last six months of life for patients with congestive heart failure. Journal of the American Geriatrics Society. 2000;48(5 Suppl):S101–S109. [PubMed: 10809463]

Li S, Ng J. End-of-life care: nurses' experiences in caring for dying patients with profound learning disabilities--a descriptive case study. Palliative Medicine. 2008;22(8):949–955. [PubMed: 18799514]

Lichter I, Hunt E. The last 48 hours of life. Journal of Palliative Care. 1990;6(4):7–15. [PubMed: 1704917]

Likar R, Molnar M, Rupacher E, Pipam W, Deutsch J, M+Ârtl M, et al. Klinische Untersuchung ++ber die Wirkung von Scopolamin-Hydrobromicum beim terminalen Rasseln (randomisierte, doppelblind, plazebokontrollierte Studie). Palliativmedizin. 2002;3(01):15–19. DOI:15.

Likar R, Rupacher E, Kager H, Molnar M, Pipam W, Sittl R. [Efficacy of glycopyrronium bromide and scopolamine hydrobromide in patients with death rattle: a randomized controlled study]. Wiener Klinische Wochenschrift. 2008;120(21-22):679–683. [PubMed: 19116709]

Lind R, Lorem GF, Nortvedt P, Hevroy O. Family members' experiences of “wait and see” as a communication strategy in end-of-life decisions. Intensive Care Medicine. 2011;37(7):1143–1150. [PMC free article: PMC3126999] [PubMed: 21626240]

Lind R, Nortvedt P, Lorem G, Hevroy O. Family involvement in the end-of-life decisions of competent intensive care patients. Nursing Ethics. 2013;20(1):61–71. [PubMed: 22918060]

Lindley-Davis B. Process of dying. Defining characteristics. Cancer Nursing. 1991;14(6):328–333. [PubMed: 1760804]

Lindqvist O, Lundquist G, Dickman A, Bukki J, Lunder U, Hagelin CL, et al. Four essential drugs needed for quality care of the dying: a Delphi-study based international expert consensus opinion. Journal of Palliative Medicine. 2013;16(1):38–43. [PubMed: 23234300]

Lindqvist O, Rasmussen BH, Widmark A, Hyden LC. Time and bodily changes in advanced prostate cancer: talk about time as death approaches. Journal of Pain and Symptom Management. 2008;36(6):648–656. [PubMed: 18504095]

Liu Y, Zhang PY, Na J, Ma C, Huo WL, Han L, et al. Prevalence, intensity, and prognostic significance of common symptoms in terminally ill cancer patients. Journal of Palliative Medicine. 2013;16(7):752–757. [PubMed: 23697815]

Loekito E, Bailey J, Bellomo R, Hart GK, Hegarty C, Davey P, et al. Common laboratory tests predict imminent death in ward patients. Resuscitation. 2013;84(3):280–285. [PubMed: 22863543]

Loekito E, Bailey J, Bellomo R, Hart GK, Hegarty C, Davey P, et al. Common laboratory tests predict imminent medical emergency team calls, intensive care unit admission or death in emergency department patients. Emergency Medicine Australasia. 2013;25(2):132–139. [PubMed: 23560963]

Lofmark R, Nilstun T, Bolmsjo IA. From cure to palliation: staff communication, documentation, and transfer of patient. Journal of Palliative Medicine. 2005;8(6) [PubMed: 16351522]

Lokker ME, van Zuylen L, van der Rijt CCD, van der Heide A. Prevalence, impact, and treatment of death rattle: a systematic review. Journal of Pain and Symptom Management. 2014;47(1):105–122. [PubMed: 23790419]

Lorenz KA, Lynn J, Dy SM, Shugarman LR, Wilkinson A, Mularski RA, et al. Evidence for improving palliative care at the end of life: a systematic review. Ann Intern Med. 2008;148(2):147–159. [PubMed: 18195339]

Lundquist G, Rasmussen BH, Axelsson B. Information of imminent death or not: does it make a difference? Journal of Clinical Oncology. 2011;29(29):3927–3931. [PubMed: 21911715]

Lutz S, Norrell R, Bertucio C, Kachnic L, Johnson C, Arthur D, et al. Symptom frequency and severity in patients with metastatic or locally recurrent lung cancer: a prospective study using the Lung Cancer Symptom Scale in a community hospital. Journal of Palliative Medicine. 2001;4(2):157–165. [PubMed: 11441624]

MacDonald RC, Weeks LE, McInnis-Perry G. End-of-life healthcare decision-making: the intermediary role of the ethicist in supporting family caregivers and health professionals. Work. 2011;40(1):63–73. [PubMed: 21849749]

Magee CL. Octreotide in the management of nausea and vomiting secondary to inoperable malignant bowel obstruction: A systematic review. Palliative Medicine. 2014;28(6):778.

Maltoni M, Scarpi E, Rosati M, Derni S, Fabbri L, Martini F, et al. Palliative sedation in end-of-life care and survival: a systematic review. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2012;30(12):1378–1383. [PubMed: 22412129]

Mangili G, Aletti G, Frigerio L, Franchi M, Panacci N, Vigano R, et al. Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis. International Journal of Gynecological Cancer. 2005;15(5):830–835. [PubMed: 16174232]

Manthous CA. Should we rescue patients with the death rattle? Critical Care Medicine. 2013;41(10):2430–2432. [PubMed: 23939360]

Marcus J. Difficult conversations: Framing a context for talking about death. Psycho-Oncology. 2014;23

Marinangeli F, Ciccozzi A, Leonardis M, Aloisio L, Mazzei A, Paladini A, et al. Use of strong opioids in advanced cancer pain: a randomized trial. Journal of Pain and Symptom Management. 2004;27(5):409–416. [PubMed: 15120769]

Masterson Creber R, Allison PD, Riegel B. Overall perceived health predicts risk of hospitalizations and death in adults with heart failure: a prospective longitudinal study. International Journal of Nursing Studies. 2013;50(5):671–677. [PMC free article: PMC4083630] [PubMed: 23122888]

Matsunuma R, Tanbo Y, Asai N, Ohkuni Y, Watanabe S, Murakami S, et al. Prognostic factors in patients with terminal stage lung cancer. Journal of Palliative Medicine. 2014;17(2):189–194. [PubMed: 24438168]

Mazzocato C, Buclin T, Rapin CH. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial. Annals of Oncology. 1999;10(12):1511–1514. [PubMed: 10643545]

Mazzocato C, Michel-Nemitz J, Anwar D, Michel P. The last days of dying stroke patients referred to a palliative care consult team in an acute hospital. European Journal of Neurology. 2010;17(1):73–77. [PubMed: 19614968]

McCarthy EP, Phillips RS, Zhong Z, Drews RE, Lynn J. Dying with cancer: patients' function, symptoms, and care preferences as death approaches. Journal of the American Geriatrics Society. 2000;48(5 Suppl):S110–S121. [PubMed: 10809464]

McLean SL, Blenkinsopp A, Bennett MI. Using haloperidol as an antiemetic in palliative care: informing practice through evidence from cancer treatment and postoperative contexts. Journal of Pain and Palliative Care Pharmacotherapy. 2013;27(2):132–135. [PubMed: 23627663]

McNamara P. Opioid switching from morphine to transdermal fentanyl for toxicity reduction in palliative care. Palliative Medicine. 2002;16(5):425–434. [PubMed: 12380661]

Mercadante S, Casuccio A, Agnello A, Serretta R, Calderone L, Barresi L. Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home. Journal of Clinical Oncology. 1998;16(11):3656–3661. [PubMed: 9817288]

Mercadante S, Casuccio A, Fulfaro F. The course of symptom frequency and intensity in advanced cancer patients followed at home. Journal of Pain and Symptom Management. 2000;20(2):104–112. [PubMed: 10989248]

Mercadante S, Ferrera P, Villari P, Adile C, Casuccio A. Switching from oxycodone to methadone in advanced cancer patients. Supportive Care in Cancer. 2012;20(1):191–194. [PubMed: 21901297]

Mercadante S, Fulfaro F, Casuccio A. A randomised controlled study on the use of anti-inflammatory drugs in patients with cancer pain on morphine therapy: effects on dose-escalation and a pharmacoeconomic analysis. European Journal of Cancer. 2002;38(10):1358–1363. [PubMed: 12091067]

Mercadante S, Villari P, Ferrera P, Casuccio A. Addition of a second opioid may improve opioid response in cancer pain: preliminary data. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 2004;12(11):762–766. [PubMed: 15206014]

Mercadante S, Porzio G, Aielli F, Ferrera P, Codipietro L, Lo Presti C, et al. The effects of low doses of pregabalin on morphine analgesia in advanced cancer patients. Clinical Journal of Pain. 2013;29(1):15–19. [PubMed: 22510538]

Mercadante SL, Berchovich M, Casuccio A, Fulfaro F, Mangione S. A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients. American Journal of Hospice and Palliative Care. 2007;24(1):13–19. [PubMed: 17347500]

Miller S, McNutt L, McCann MA, McCorry N. Use of corticosteroids for anorexia in palliative medicine: a systematic review. Journal of Palliative Medicine. 2014;17(4):482–485. [PubMed: 24702642]

Minto F, Strickland K. Anticipating emotion: a qualitative study of advance care planning in the community setting. International Journal of Palliative Nursing. 2011;17(6):278–284. [PubMed: 21727885]

Moore MJ, Osoba D, Murphy K, Tannock IF, Armitage A, Findlay B, et al. Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer. Journal of Clinical Oncology. 1994;12(4):689–694. [PubMed: 7512127]

Morgan AE, Lindley CM, Berry JI. Assessment of pain and patterns of analgesic use in hospice patients. American Journal of Hospice and Palliative Care. 1994;11(1):13–15. [PubMed: 8117486]

Morita T, Hyodo I, Yoshimi T, Ikenaga M, Tamura Y, Yoshizawa A, et al. Association between hydration volume and symptoms in terminally ill cancer patients with abdominal malignancies. Annals of Oncology : Official Journal of the European Society for Medical Oncology / ESMO. 2005;16(4):640–647. [PubMed: 15684225]

Morita T, Ichiki T, Tsunoda J, Inoue S, Chihara S. A prospective study on the dying process in terminally ill cancer patients. American Journal of Hospice and Palliative Care. 1998;15(4):217–222. [PubMed: 9729972]

Morita T, Takigawa C, Onishi H, Tajima T, Tani K, Matsubara T, et al. Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial. Journal of Pain and Symptom Management. 2005;30(1):96–103. [PubMed: 16043013]

Morita T, Tei Y, Inoue S. Agitated terminal delirium and association with partial opioid substitution and hydration. Journal of Palliative Medicine. 2003;6(4):557–563. [PubMed: 14516497]

Moyer DD. Review article: terminal delirium in geriatric patients with cancer at end of life. American Journal of Hospice and Palliative Care. 2011;28(1):44–51. [PubMed: 21057140]

Muniz-Terrera G, van den Hout A, Piccinin AM, Matthews FE, Hofer SM. Investigating terminal decline: results from a UK population-based study of aging. Psychology and Aging. 2013;28(2):377–385. [PMC free article: PMC3692590] [PubMed: 23276221]

Murphy SA, Mydin HH, Fatah S, Antunes G. Predicting end-of-life in patients with an exacerbation of COPD by routine clinical assessment. Respiratory Medicine. 2010;104(11):1668–1674. [PubMed: 20537518]

Murtagh FE, Addington-Hall J, Edmonds P, Donohoe P, Carey I, Jenkins K, et al. Symptoms in the month before death for stage 5 chronic kidney disease patients managed without dialysis. Journal of Pain and Symptom Management. 2010;40(3):342–352. [PubMed: 20580200]

Mystakidou K, Befon S, Liossi C, Vlachos L. Comparison of the efficacy and safety of tropisetron, metoclopramide, and chlorpromazine in the treatment of emesis associated with far advanced cancer. Cancer. 1998;83(6):1214–1223. [PubMed: 9740088]

Mystakidou K, Katsouda E, Kouloulias V, Kouvaris J, Tsiatas M, Vlahos L. Comparison of transdermal fentanyl with codeine/paracetamol, in combination with radiotherapy, for the management of metastatic bone pain. Journal of Opioid Management. 2005;1(4):204–210. [PubMed: 17315548]

Mystakidou K, Kouloulias V, Nikolaou V, Tsilika E, Lymperopoulou G, Balafouta M, et al. A comparative study of prophylactic antiemetic treatment in cancer patients receiving radiotherapy. Journal of B U ON. 2010;15(1):29–35. [PubMed: 20414924]

Mystakidou K, Tsilika E, Parpa E, Papageorgiou C, Georgaki S, Vlahos L. Investigating the effects of TTS-fentanyl for cancer pain on the psychological status of patients naive to strong opioids: an open label study. Cancer Nursing. 2004;27(2):127–133. [PubMed: 15253170]

Naing C, Aung K, Racloz V, Yeoh PN. Safety and efficacy of transdermal buprenorphine for the relief of cancer pain. Journal of Cancer Research and Clinical Oncology. 2013;139(12):1963–1970. [PubMed: 23922192]

Naqvi F, Cervo F, Fields S. Evidence-based review of interventions to improve palliation of pain, dyspnea, depression. Geriatrics. 2009;64(8):8–4. [PubMed: 20722311]

National Clinical Guideline Centre. Patient experience in adult NHS services: improving the experience of care for people using adult NHS services. London: National Clinical Guideline Centre; 2012. (NICE clinical guideline 138). Available from: http://www​.nice.org.uk/CG138.

National Institute for Health and Clinical Excellence. The guidelines manual. London: National Institute for Health and Clinical Excellence; 2012. Available from: http://publications​.nice​.org.uk/the-guidelines-manual-pmg6/ [PubMed: 27905714]

Nava S, Ferrer M, Esquinas A, Scala R, Groff P, Cosentini R, et al. Palliative use of non-invasive ventilation in end-of-life patients with solid tumours: a randomised feasibility trial. Lancet Oncology. 2013;14(3):219–227. [PubMed: 23406914]

Navigante AH, Cerchietti LCA, Cabalar ME. Morphine plus midazolam versus oxygen therapy on severe dyspnea management in the last week of life in hipoxemic advanced cancer patients [Spanish] Medicina Paliativa. 2003;10(1):14–19.

Navigante AH, Cerchietti LCA, Castro MA, Lutteral MA, Cabalar ME. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. Journal of Pain and Symptom Management. 2006;31(1):38–47. [PubMed: 16442481]

Nedjat-Haiem FR. Getting to end-of-life discussions in advanced cancer care: Barriers and attitudes that limit end of life communication for disadvantaged Latinos. Dissertation Abstracts International Section A: Humanities and Social Sciences. 2011;71(9-A)

NHS Business Services Authority. NHS electronic drug tariff: December 2014. 2014. [1 December 14 A.D.]. Available from: http://www​.ppa.org.uk​/edt/December_2014/mindex.htm.

NHS Business Services Authority. NHS electronic drug tariff: March 2015. 2015. [1 March 15 A.D.]. Available from: http://www​.ppa.org.uk​/edt/March_2015/mindex.htm.

Nicholson AB. Methadone for cancer pain. Cochrane Database of Systematic Reviews. 2007;(4) John Wiley & Sons, Ltd. [PubMed: 17943808]

Nolan MT, Kub J, Hughes MT, Terry PB, Astrow AB, Carbo CA, et al. Family health care decision making and self-efficacy with patients with ALS at the end of life. Palliative and Supportive Care. 2008;6(3):273–280. [PMC free article: PMC2572768] [PubMed: 18662421]

Nordgren L, Sorensen S. Symptoms experienced in the last six months of life in patients with end-stage heart failure. European Journal of Cardiovascular Nursing. 2003;2(3):213–217. [PubMed: 14622629]

Norton SA, Talerico KA. Facilitating end-of-life decision-making: strategies for communicating and assessing. Journal of Gerontological Nursing. 2000;26(9) [PMC free article: PMC3732104] [PubMed: 11883616]

Norton SA, Metzger M, DeLuca J, Alexander SC, Quill TE, Gramling R. Palliative care communication: linking patients' prognoses, values, and goals of care. Research in Nursing and Health. 2013;36(6) [PubMed: 24114740]

Nunn C. It's not just about pain: Symptom management in palliative care. Nurse Prescribing. 2014;12(7):338–344.

Nwosu AC, Mayland CR, Mason SR, Khodabukus AF, Varro A, Ellershaw JE. Hydration in advanced cancer: can bioelectrical impedance analysis improve the evidence base? A systematic review of the literature. Journal of Pain and Symptom Management. 2013;46(3):433–446. [PubMed: 23200189]

O'Neill J, Fountain A. Levomepromazine (methotrimeprazine) and the last 48 hours. Hospital Medicine. 1999;60(8):564–567. [PubMed: 10621810]

Oberle K, Hughes D. Doctors' and nurses' perceptions of ethical problems in end-of-life decisions. Journal of Advanced Nursing. 2001;33(6):707–715. [PubMed: 11298208]

Olajide O, Hanson L, Usher BM, Qaqish BF, Schwartz R, Bernard S. Validation of the palliative performance scale in the acute tertiary care hospital setting. Journal of Palliative Medicine. 2007;10(1):111–117. [PubMed: 17298259]

Oliver MA, Hillock S, Moore C, Goble H, Asbury N. Comfort care packs: a little bit of hospice in hospital? International Journal of Palliative Nursing. 2010;16(10):511–515. [PubMed: 20972384]

Ostertag SG, Forman WB. End-of-life care in Hancock County, Maine: a community snapshot. American Journal of Hospice and Palliative Care. 2008;25(2):132–138. [PubMed: 18198365]

Ostgathe C, Gaertner J, Voltz R. Cognitive failure in end of life. Current Opinion in Supportive and Palliative Care. 2008;2(3):187–191. [PubMed: 18685419]

Oxberry SG, Lawrie I. Symptom control and palliative care: management of breathlessness. British Journal of Hospital Medicine. 2009;70(4):212–216. [PubMed: 19357599]

Pace A, Di Lorenzo C, Guariglia L, Jandolo B, Carapella CM, Pompili A. End of life issues in brain tumor patients. Journal of Neuro-Oncology. 2009;91(1):39–43. [PubMed: 18704267]

Palmer J, Stephen N, Endacott R. Facilitating end-of-life discussions in users of home mechanical ventilation that have a life-limiting neuromuscular disease. Thorax. 2012;67

Parlow JL, Milne B, Tod DA, Stewart GI, Griffiths JM, Dudgeon DJ. Self-administered nitrous oxide for the management of incident pain in terminally ill patients: a blinded case series. Palliative Medicine. 2005;19(1):3–8. [PubMed: 15690862]

Peppin JF. Intractable symptoms and palliative sedation at the end of life. Christian Bioethics. 2003;9(2-3):343–355. [PubMed: 15255002]

Perkins P, Dorman S. Haloperidol for the treatment of nausea and vomiting in palliative care patients. Cochrane Database of Systematic Reviews. 2009;(2) CD006271. [PubMed: 19370630] [CrossRef]

Peterson GM, Young RS, Dunne PF, Galloway JG, Parks TE. Pilot study of nebulised morphine for dyspnoea in palliative care patients. Australian Journal of Hospital Pharmacy. 1996;26(5):545–547.

Philip J, Gold M, Milner A, Di Iulio J, Miller B, Spruyt O. A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer. Journal of Pain and Symptom Management. 2006;32(6):541–550. [PubMed: 17157756]

Pinzon LCE, Claus M, Perrar KM, Zepf KI, Letzel S, Weber M. Dying with dementia: symptom burden, quality of care, and place of death. Deutsches Arzteblatt International. 2013;110(12):195–202. [PMC free article: PMC3622236] [PubMed: 23589742]

Plonk WM Jr., Arnold RM. Terminal care: the last weeks of life. Journal of Palliative Medicine. 2005;8(5):1042–1054. [PubMed: 16238518]

Popiela T, Lucchi R, Giongo F. Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group. European Journal of Cancer and Clinical Oncology. 1989;25(12):1823–1829. [PubMed: 2483687]

Potter JM, Fernando R, Humpel N. Development and evaluation of the REACH (recognise end of life and care holistically) out in dementia toolkit. Australasian Journal on Ageing. 2013;32(4):241–246. [PubMed: 24251787]

Price MA, Bell ML, Sommeijer DW, Friedlander M, Stockler MR, Defazio A, et al. Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: A prospective population-based study over the last year of life. Gynecologic Oncology. 2013;130(1):162–168. [PubMed: 23578538]

Prommer E. Role of Haloperidol in Palliative Medicine: An Update. American Journal of Hospice and Palliative Medicine. 2012;29(4):295–301. [PubMed: 21998445]

Prommer E. Olanzapine: palliative medicine update. American Journal of Hospice and Palliative Care. 2013;30(1):75–82. [PubMed: 22495793]

Puntillo KA, McAdam JL. Communication between physicians and nurses as a target for improving end-of-life care in the intensive care unit: challenges and opportunities for moving forward. Critical Care Medicine. 2006;34(11 Suppl) [PubMed: 17057595]

Radbruch L, Hoffmann-Menzel H, Kern M, Rolke R. Hospice pharmaceutical care: The care for the dying. European Journal of Hospital Pharmacy: Science and Practice. 2012;19(1):45–48.

Radbruch L, Strasser F, Elsner F, Goncalves JF, Loge J, Kaasa S, et al. Fatigue in palliative care patients -- an EAPC approach. Palliative Medicine. 2008;22(1):13–32. [PubMed: 18216074]

Radley J. Time savers. Nursing Standard. 1998;12(28):20.

Radwany S, Albanese T, Clough L, Sims L, Mason H, Jahangiri S. End-of-life decision making and emotional burden: placing family meetings in context. American Journal of Hospice and Palliative Care. 2009;26(5):376–383. [PubMed: 19571324]

Raffa RB, Pergolizzi JVJ. Intracerebroventricular opioids for intractable pain. British Journal of Clinical Pharmacology. 2012;74(1):34–41. [PMC free article: PMC3394126] [PubMed: 22295988]

Randhawa G, Owens A, Fitches R, Khan Z. Communication in the development of culturally competent palliative care services in the UK: a case study. International Journal of Palliative Nursing. 2003;9(1) [PubMed: 12560794]

Rashidi NM, Zordan RD, Flynn E, Philip JAM. The care of the very old in the last three days of life. Journal of Palliative Medicine. 2011;14(12):1339–1344. [PubMed: 22145894]

Rauck RL, Tark M, Reyes E, Hayes TG, Bartkowiak AJ, Hassman D, et al. Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain. Current Medical Research and Opinion. 2009;25(12):2877–2885. [PubMed: 19814586]

Reed T. How effective is the preferred priorities of care document? Nursing Times. 2011;107(18):14–17. [PubMed: 21678748]

Reinke LF, Engelberg RA, Shannon SE, Wenrich MD, Vig EK, Back AL, et al. Transitions regarding palliative and end-of-life care in severe chronic obstructive pulmonary disease or advanced cancer: themes identified by patients, families, and clinicians. Journal of Palliative Medicine. 2008;11(4) [PMC free article: PMC4484272] [PubMed: 18454613]

Reinke LF, Shannon SE, Engelberg RA, Young JP, Curtis JR. Supporting hope and prognostic information: nurses' perspectives on their role when patients have life-limiting prognoses. Journal of Pain and Symptom Management. 2010;39(6) [PMC free article: PMC2884140] [PubMed: 20538182]

Rhondali W, Dev R, Barbaret C, Chirac A, Font-Truchet C, Vallet F, et al. Family conferences in palliative care: a survey of health care providers in france. Journal of Pain and Symptom Management. 2014;48(6) [PubMed: 24780185]

Richards CT, Gisondi MA, Chang CH, Courtney DM, Engel KG, Emanuel L, et al. Palliative care symptom assessment for patients with cancer in the emergency department: validation of the Screen for Palliative and End-of-life care needs in the Emergency Department instrument. Journal of Palliative Medicine. 2011;14(6):757–764. [PMC free article: PMC3107583] [PubMed: 21548790]

Ridley S, Fisher M. Uncertainty in end-of-life care. Current Opinion in Critical Care. 2013;19(6):642–647. [PubMed: 24220000]

Ripamonti C. Management of dyspnea in advanced cancer patients. Supportive Care in Cancer. 1999;7(4):233–243. [PubMed: 10423049]

Ripamonti C, Mercadante S, Groff L, Zecca E, De Conno F, Casuccio A. Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. Journal of Pain and Symptom Management. 2000;19(1):23–34. [PubMed: 10687323]

Roberts DK, Thorne SE, Pearson C. The experience of dyspnea in late-stage cancer. Patients' and nurses' perspectives. Cancer Nursing. 1993;16(4):310–320. [PubMed: 7691396]

Rodrigues P, Hering F, Campagnari JC. Use of bisphosphonates can dramatically improve pain in advanced hormone-refractory prostate cancer patients. Prostate Cancer and Prostatic Diseases. 2004;7(4):350–354. [PubMed: 15534620]

Rodriguez RF, Bravo LE, Castro F, Montoya O, Castillo JM, Castillo MP, et al. Incidence of weak opioids adverse events in the management of cancer pain: a double-blind comparative trial. Journal of Palliative Medicine. 2007;10(1):56–60. [PubMed: 17298254]

Roscoe LA, Tullis JA, Reich RR, McCaffrey JC. Beyond good intentions and patient perceptions: competing definitions of effective communication in head and neck cancer care at the end of life. Health Communication. 2013;28(2) [PubMed: 22574841]

Royak-Schaler R, Gadalla S, Lemkau J, Ross D, Alexander C, Scott D. Family perspectives on communication with healthcare providers during end-of-life cancer care. Oncology Nursing Forum. 2006;33(4):753–760. [PubMed: 16858457]

Ryan K, Guerin S, Dodd P, McEvoy J. End-of-life care for people with intellectual disabilities: Paid carer perspectives. Journal of Applied Research in Intellectual Disabilities. 2011;24(3):199–207. DOI: http://dx​.doi.org/10​.1111/j.1468-3148.2010.00605.x.

Saini T, Murtagh FEM, Dupont PJ, McKinnon PM, Hatfield P, Saunders Y. Comparative pilot study of symptoms and quality of life in cancer patients and patients with end stage renal disease. Palliative Medicine. 2006;20(6):631–636. [PubMed: 17060257]

Salas S, Frasca M, Planchet-Barraud B, Burucoa B, Pascal M, Lapiana JM, et al. Ketamine analgesic effect by continuous intravenous infusion in refractory cancer pain: considerations about the clinical research in palliative care. Journal of Palliative Medicine. 2012;15(3):287–293. [PubMed: 22335487]

Salpeter SR, Malter DS, Luo EJ, Lin AY, Stuart B. Systematic review of cancer presentations with a median survival of six months or less. Journal of Palliative Medicine. 2012;15(2):175–185. [PubMed: 22023378]

Samara J, Larkin D, Chan CW, Lopez V. Advance care planning in the oncology settings. International Journal of Evidence-Based Healthcare. 2013;11(2):110–114. [PubMed: 23750573]

Sayed MM. The effect of systemic steroids on the incidence of bone pain flare with palliative Irradiation. Middle East Journal of Cancer. 2014;5(2):83–89.

Schultheis CP. Nebulized fentanyl provides subjective improvements for patients with dyspnea. Oncology Nursing Forum. 2005;32(1):15. [PubMed: 15682527]

Scott-Aiton A. Creating a tool to improve anticipatory prescribing in palliative care. Pharmaceutical Journal. 2009;283(7569):283–284.

Seah STA, Low JA, Chan YH. Symptoms and care of dying elderly patients in an acute hospital. Singapore Medical Journal. 2005;46(5):210–214. [PubMed: 15858688]

Seymour J, Almack K, Kennedy S. Implementing advance care planning: a qualitative study of community nurses' views and experiences. BMC Palliative Care. 2010;9:4. [PMC free article: PMC2854100] [PubMed: 20377876]

Sheehan C, Clark K, Lam L, Chye R. A retrospective analysis of primary diagnosis, comorbidities, anticholinergic load, and other factors on treatment for noisy respiratory secretions at the end of life. Journal of Palliative Medicine. 2011;14(11):1211–1216. [PubMed: 21883008]

Shimizu Y, Miyashita M, Morita T, Sato K, Tsuneto S, Shima Y. Care strategy for death rattle in terminally ill cancer patients and their family members: recommendations from a cross-sectional nationwide survey of bereaved family members' perceptions. Journal of Pain and Symptom Management. 2014;48(1):2–12. [PubMed: 24161372]

Sim SW, Ho S, Kumar RKL. Use of Opioids and Sedatives at End-of-Life. Indian Journal of Palliative Care. 2014;20(2):160–165. [PMC free article: PMC4130007] [PubMed: 25125876]

Simon ST, Koskeroglu P, Bausewein C. Pharmacological therapy of refractory dyspnoea : a systematic literature review. Schmerz. 2012;26(5):515–522. [PubMed: 22956077]

Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database of Systematic Reviews. 2010;(1) John Wiley & Sons, Ltd. [PubMed: 20091630]

Sittl R, Griessinger N, Likar R. Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial. Clinical Therapeutics. 2003;25(1):150–168. [PubMed: 12637117]

Skaug K, Eide GE, Gulsvik A. Prevalence and predictors of symptoms in the terminal stage of lung cancer: A community study. Chest. 2007;131(2):389–394. [PubMed: 17296638]

Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. Journal of Clinical Oncology. 2002;20(19):4040–4049. [PubMed: 12351602]

Smucker WD. Palliative and end-of-life care in LTC: Evaluation and treatment of dyspnea, death rattle, and myoclonus. Annals of Long-Term Care. 2010;18(5):37–41.

Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. Journal of Pain and Symptom Management. 2006;31(1):58–69. [PubMed: 16442483]

Spoozak L, Seow H, Liu Y, Wright J, Barbera L. Performance status and symptom scores of women with gynecologic cancer at the end of life. International Journal of Gynecological Cancer. 2013;23(5):971–978. [PubMed: 23666015]

Stallworthy EJ, Davison SN, Pilmore HL, O'Callaghan A, Dittmer ID. Survey of end-of-life care preferences and needs of long-term haemodialysis patients in the Auckland District health board area. Nephrology. 2014;19

Stevens I, Whyte F. Advance care planning: will it work in diseases other than cancer? European Journal of Palliative Care. 2011;18(6):280–284.

Stiefel F, Stagno D. Management of insomnia in patients with chronic pain conditions. CNS Drugs. 2004;18(5):285–296. [PubMed: 15089114]

Stone L, Kinley J, Hockley J. Advance care planning in care homes: the experience of staff, residents, and family members. International Journal of Palliative Nursing. 2013;19(11):550–557. [PubMed: 24263899]

Strassels SA, Blough DK, Veenstra DL, Hazlet TK, Sullivan SD. Clinical and demographic characteristics help explain variations in pain at the end of life. Journal of Pain and Symptom Management. 2008;35(1):10–19. [PubMed: 17959344]

Suh SY, Choi YS, Yeom CH, Kwak SM, Yoon HM, Kim DG, et al. Interleukin-6 but not tumour necrosis factor-alpha predicts survival in patients with advanced cancer. Supportive Care in Cancer. 2013;21(11):3071–3077. [PubMed: 23828393]

Sullivan AM, Lakoma MD, Matsuyama RK, Rosenblatt L, Arnold RM, Block SD. Diagnosing and discussing imminent death in the hospital: a secondary analysis of physician interviews. Journal of Palliative Medicine. 2007;10(4):882–893. [PubMed: 17803409]

Tan A, Manca D. Finding common ground to achieve a “good death”: family physicians working with substitute decision-makers of dying patients. A qualitative grounded theory study. BMC Family Practice. 2013;14:14. [PMC free article: PMC3556163] [PubMed: 23339822]

Tang S, Liu TW, Liu L, Chiu CF, Hsieh RK, Tsai CM. Physician–patient end-of-life care discussions: Correlates and associations with end-of-life care preferences of cancer patients—a cross-sectional survey study. Palliative Medicine. 2014;28(10) [PubMed: 24965755]

Tatum P. Haloperidol for nausea and vomiting. Journal of Pain and Palliative Care Pharmacotherapy. 2009;23(4):426–427.

Thomas JR, Wallace MS, Yocum RC, Vaughn DE, Haller MF, Flament J. The INFUSE-Morphine study: use of recombinant human hyaluronidase (rHuPH20) to enhance the absorption of subcutaneously administered morphine in patients with advanced illness. Journal of Pain and Symptom Management. 2009;38(5):663–672. [PubMed: 19819665]

Thompson TD, Barbour RS, Schwartz L. Health professionals' views on advance directives: a qualitative interdisciplinary study. Palliative Medicine. 2003;17(5):403–409. [PubMed: 12882258]

Tilden VP, Tolle SW, Garland MJ, Nelson CA. Decisions about life-sustaining treatment. Impact of physicians' behaviors on the family. Archives of Internal Medicine. 1995;155(6):633–638. [PubMed: 7887760]

Tomlinson K, Barker S, Soden K. What are cancer patients' experiences and preferences for the provision of written information in the palliative care setting? A focus group study. Palliative Medicine. 2012;26(5) [PubMed: 21908521]

Trueman J, Trueman I. COPD: criteria to assist in the identification of the palliative phase. British Journal of Nursing. 2011;20(10):635–639. [PubMed: 21646997]

Tsai JS, Wu CH, Chiu TY, Hu WY, Chen CY. Symptom patterns of advanced cancer patients in a palliative care unit. Palliative Medicine. 2006;20(6):617–622. [PubMed: 17060255]

Tse MMY, Wong ACF, Ng HN, Lee HY, Chong MH, Leung WY. The effect of a pain management program on patients with cancer pain. Cancer Nursing. 2012;35(6):438–446. [PubMed: 22228392]

Tuca A, Roca R, Sala C, Porta J, Serrano G, Gonzalez-Barboteo J, et al. Efficacy of granisetron in the antiemetic control of nonsurgical intestinal obstruction in advanced cancer: a phase II clinical trial. Journal of Pain and Symptom Management. 2009;37(2):259–270. [PubMed: 18789638]

Twomey S, Dowling M. Management of death rattle at end of life. British Journal of Nursing. 2013;22(2):81–85. [PubMed: 23587890]

Twycross RG. Choice of strong analgesic in terminal cancer: diamorphine or morphine? Pain. 1977;3(2):93–104. [PubMed: 69290]

Twycross RG, Guppy D. Prednisolone in terminal breast and bronchogenic cancer. Practitioner. 1985;229(1399):57–59. [PubMed: 2581241]

Twycross RG, Wilcock A. Palliative Care Formularly. 2011.

Uronis HE, Currow DC, McCrory DC, Samsa GP, Abernethy AP. Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis. British Journal of Cancer. 2008;98(2):294–299. [PMC free article: PMC2361446] [PubMed: 18182991]

Uronis HE, Abernethy AP. Oxygen for relief of dyspnea: what is the evidence? Current Opinion in Supportive and Palliative Care. 2008;2(2):89–94. [PubMed: 18685402]

Van Der Wal MHL, Hjelmfors L, Stromberg A, Jaarsma T. Nurses perspectives on discussing prognosis and end-of-life in heart failure patients. European Heart Journal. 2014;35

van der Werff GF, Paans W, Nieweg RM. Hospital nurses' views of the signs and symptoms that herald the onset of the dying phase in oncology patients. International Journal of Palliative Nursing. 2012;18(3):143–149. [PubMed: 22584315]

Vandervoort A, Van den Block L, van der Steen JT, Volicer L, Vander Stichele R, Houttekier D, et al. Nursing home residents dying with dementia in Flanders, Belgium: a nationwide postmortem study on clinical characteristics and quality of dying. Journal of the American Medical Directors Association. 2013;14(7):485–492. [PubMed: 23523319]

Veerbeek L, van Zuylen L, Swart SJ, van der Maas PJ, van der Heide A. The last 3 days of life in three different care settings in The Netherlands. Supportive Care in Cancer. 2007;15(10):1117–1123. [PubMed: 17357794]

Ventafridda V, Ripamonti C, De Conno F, Tamburini M, Cassileth BR. Symptom prevalence and control during cancer patients' last days of life. Journal of Palliative Care. 1990;6(3):7–11. [PubMed: 1700099]

Vig EK, Starks H, Taylor JS, Hopley EK, Fryer-Edwards K. Surviving surrogate decision-making: What helps and hampers the experience of making medical decisions for others. Journal of General Internal Medicine. 2007;22(9):1274–1279. [PMC free article: PMC2219771] [PubMed: 17619223]

Viola R. Studying Fluid Status and the Dying: The Challenge of Clinical Research in Palliative Care. 1997.

Viola R, Kiteley C, Lloyd NS, Mackay JA, Wilson J, Wong RKS, et al. The management of dyspnea in cancer patients: a systematic review. Supportive Care in Cancer. 2008;16(4):329–337. [PubMed: 18214551]

Vitacca M, Comini L. How do patients die in a rehabilitative unit dedicated to advanced respiratory diseases? Multidisciplinary Respiratory Medicine. 2012;7(1):18. [PMC free article: PMC3436688] [PubMed: 22958591]

von Gunten CF. Interventions to manage symptoms at the end of life. Journal of Palliative Medicine. 2005;8(Suppl 1):S88–S94. [PubMed: 16499473]

Voorhees J, Rietjens J, Onwuteaka-Philipsen B, Deliens L, Cartwright C, Faisst K, et al. Discussing prognosis with terminally ill cancer patients and relatives: a survey of physicians' intentions in seven countries. Patient Education and Counseling. 2009;77(3) [PubMed: 19850436]

Vvedenskaya E, Moshkovich G, Petrushov P, Bykova L. End-of-life care communication barriers for doctors and patients with advanced HIV disease. Palliative Medicine. 2010;24(4 SUPPL. 1)

Vvedenskaya E, Sokolova E. End-of-life communication barriers for doctors and patients with advanced cancer. Supportive Care in Cancer. 2012;20

Vvedenskaya E, Vvedenskaya I, Shilova O, Kobzeva L. End-of-life care communication barriers for doctors and cancer patients. Pediatric Blood and Cancer. 2009;53(5)

Wadensten B, Conden E, Wahlund L, Murray K. How nursing home staff deal with residents who talk about death. International Journal of Older People Nursing. 2007;2(4) [PubMed: 20925838]

Walbert T, Khan M. End-of-life symptoms and care in patients with primary malignant brain tumors: A systematic literature review. Journal of Neuro-Oncology. 2014;117(2):217–224. [PubMed: 24522718]

Walczak A, Butow PN, Tattersall MHN, Clayton JM, Young JM, Davidson PM, et al. Optimising discussions of prognosis and end-of-life issues in advanced cancer: A Qualitative interview study. Asia-Pacific Journal of Clinical Oncology. 2010;6

Walczak A, Butow PN, Davidson PM, Bellemore FA, Tattersall MHN, Clayton JM, et al. Patient perspectives regarding communication about prognosis and end-of-life issues: how can it be optimised? Patient Education and Counseling. 2013;90(3) [PubMed: 21920693]

Waldrop DP, Meeker MA, Kerr C, Skretny J, Tangeman J, Milch R. The nature and timing of family-provider communication in late-stage cancer: A qualitative study of caregivers' experiences. Journal of Pain and Symptom Management. 2012;43(2) [PubMed: 22248787]

Waller A, Hershkowitz M, Adunsky A. The effect of intravenous fluid infusion on blood and urine parameters of hydration and on state of consciousness in terminal cancer patients. American Journal of Hospice and Palliative Care. 1994;11(6):22–27. [PubMed: 7893564]

Wang EHZ, Mabasa VH, Loh GW, Ensom MHH. Haloperidol dosing strategies in the treatment of delirium in the critically-ill. Neurocritical Care. 2012;16(1):170–183. [PubMed: 22038577]

Weinandy D. An analysis of the communication of hospital nurses and terminally ill patients [Ph.D.]. Bowling Green State University; 1997.

Wenrich MD, Curtis JR, Shannon SE, Carline JD, Ambrozy DM, Ramsey PG. Communicating with dying patients within the spectrum of medical care from terminal diagnosis to death. Archives of Internal Medicine. 2001;161(6) [PubMed: 11268231]

Wiffen PJ, Derry S, Moore RA. Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain. Cochrane Database of Systematic Reviews. 2014;(5) John Wiley & Sons, Ltd. [PMC free article: PMC6483540] [PubMed: 24874470]

Wildiers H, Dhaenekint C, Demeulenaere P, Clement PMJ, Desmet M, Van Nuffelen R, et al. Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care. Journal of Pain and Symptom Management. 2009;38(1):124–133. [PubMed: 19361952]

Wilkinson E, Randhawa G, Brown EA, Da Silva Gane M, Stoves J, Warwick G, et al. Communication as care at end of life: an emerging issue from an exploratory action research study of renal end-of-life care for ethnic minorities in the UK. Journal of Renal Care. 2014 40 Suppl 1 [PubMed: 25185489]

Willard C, Luker K. Challenges to end of life care in the acute hospital setting. Palliative Medicine. 2006;20(6):611–615. [PubMed: 17060254]

Williams M. Applicability and generalizability of palliative interventions for dyspnoea: one size fits all, some or none? Current Opinion in Supportive and Palliative Care. 2011;5(2):92–100. [PubMed: 21519300]

Wilson E, Morbey H, Brown J, Payne S, Seale C, Seymour J. Administering anticipatory medications in end-of-life care: A qualitative study of nursing practice in the community and in nursing homes. Palliative Medicine. 2015;29(1):60–70. [PMC free article: PMC4266693] [PubMed: 25070861]

Witkamp E, van ZL, van der Heide A. Communication about dying in a dutch hospital. Palliative Medicine. 2010;24(4 SUPPL. 1)

Wootton M. Morphine is not the only analgesic in palliative care: literature review. Journal of Advanced Nursing. 2004;45(5):527–532. [PubMed: 15009356]

Wyne A, Rai R, Cuerden M, Clark WF, Suri RS. Opioid and benzodiazepine use in end-stage renal disease: a systematic review. Clinical Journal of the American Society of Nephrology. 2011;6(2):326–333. [PMC free article: PMC3052223] [PubMed: 21071517]

Xu G-Z, Cai Z-J, Deng Y-P, Hou J, Xie G-R, Liu S-J. Clinical evaluation of the analgesic effect of sustained release morphine sulfate microgranules in patients with terminal cancer. Clinical Drug Investigation. 1997;14(SUPPL. 1):34–42.

Yamanaka R, Koga H, Yamamoto Y, Yamada S, Sano T, Fukushige T. Characteristics of patients with brain metastases from lung cancer in a palliative care center. Supportive Care in Cancer. 2011;19(4):467–473. [PubMed: 20217148]

Yanneo EG. Determining prognosis and predicting survival in end-of-life care. Current Opinion in Supportive and Palliative Care. 2009;3(3):203–206. [PubMed: 19550333]

Yates P, Schofield P, Zhao I, Currow D. Supportive and palliative care for lung cancer patients. Journal of Thoracic Disease. 2013 5 Suppl 5:S623–S628. [PMC free article: PMC3804870] [PubMed: 24163753]

Yin OS, Xia Z, Yi X, Chia DTC. Nurses' perceptions towards caring for dying patients in oncology ward and general surgical ward. Singapore Nursing Journal. 2007;34(3)

Yong DSP, Kwok AOL, Wong DML, Suen MHP, Chen WT, Tse DMW. Symptom burden and quality of life in end-stage renal disease: a study of 179 patients on dialysis and palliative care. Palliative Medicine. 2009;23(2):111–119. [PubMed: 19153131]

You JJ, Dodek P, Lamontagne F, Downar J, Sinuff T, Jiang X, et al. What really matters in end-of-life discussions? Perspectives of patients in hospital with serious illness and their families. CMAJ. 2014;186(18) [PMC free article: PMC4259796] [PubMed: 25367427]

Young AJ, Rodriguez KL. The role of narrative in discussing end-of-life care: eliciting values and goals from text, context, and subtext. Health Communication. 2006;19(1) [PubMed: 16519592]

Zambroski CH, Moser DK, Roser LP, Heo S, Chung ML. Patients with heart failure who die in hospice. American Heart Journal. 2005;149(3):558–564. [PubMed: 15864247]

Zeppetella G. An assessment of the safety, efficacy, and acceptability of intranasal fentanyl citrate in the management of cancer-related breakthrough pain: a pilot study. Journal of Pain and Symptom Management. 2000;20(4):253–258. [PubMed: 11027906]

Zeppetella G. Sublingual fentanyl citrate for cancer-related breakthrough pain: a pilot study. Palliative Medicine. 2001;15(4):323–328. [PubMed: 12054149]

Zeppetella G, Messina J, Xie F, Slatkin NE. Consistent and clinically relevant effects with fentanyl buccal tablet in the treatment of patients receiving maintenance opioid therapy and experiencing cancer-related breakthrough pain. Pain Practice. 2010;10(4):287–293. [PubMed: 20230447]

Zerzan J, Benton K, Linnebur S, O'Bryant C, Kutner J. Variation in pain medication use in end-of-life care. Journal of Palliative Medicine. 2010;13(5):501–504. [PubMed: 20420544]